皮膚科臨床アセット　18　紅斑と痒疹

出版社： 中山書店
著者：
発行日： 2013-12-25
分野： 臨床医学：内科  >  皮膚科
ISBN： 9784521733555
シリーズ： 皮膚科臨床アセット
電子書籍版： 2013-12-25 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

15,950 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

15,950 円(税込)

購入する

商品紹介

日常臨床でよく遭遇するにもかかわらず，疾患としての理解が難しい紅斑症および痒疹を解説する．紅斑症では，多形滲出性紅斑など代表的疾患の病態・診断・治療を記載するほか，近年注目されている中條-西村症候群も収載した．痒疹では新しく策定された診療ガイドラインをもとに慢性痒疹を詳述のうえ，ほかに妊娠，内臓悪性腫瘍，金属アレルギーなどに伴う痒疹を取り上げた．

目次

  • 皮膚科臨床アセット　18　紅斑と痒疹

    ―目次―

    I　紅斑症
    　１．紅斑の分類と臨床検査・治療指針
    　２．紅斑の発症メカニズム
    　３．紅斑症の病理診断学　
    　４．多形滲出性紅斑の概念・分類・診断　
    　５．多形滲出性紅斑の病態と感染性病原体の関与
    　６．薬剤による多形滲出性紅斑の最新知見
    　７．多形滲出性紅斑の治療法
    　８．結節性紅斑の概念・病態・症状
    　９．結節性紅斑の診断・鑑別診断・治療　
    　10．Bazin硬結性紅斑の概念・病態・診断・治療
    　11．持続性隆起性紅斑の概念・病態・診断・治療　
    　12．Sweet病の概念・病態・診断・治療　
    　13．Behcet病の概念・疫学・病態
    　14．Behcet病の粘膜・皮膚症状
    　15．Behcet病の診断・鑑別診断・治療
    　16．関節リウマチに伴う紅斑の症状・診断・治療
    　17．成人Still病に伴う紅斑の症状・診断・治療
    　18．環状紅斑の概念・分類
    　19．遠心性環状紅斑の病態・診断・治療
    　20．慢性遊走性紅斑の病態・診断・治療　
    　21．亜急性皮膚エリテマトーデスの環状紅斑の病態・診断・治療
    　22．Sjogren症候群の環状紅斑の病態・診断・治療　
    　23．悪性腫瘍に伴う環状紅斑の分類・診断・治療
    　24．幼小児の環状紅斑の分類・病態・診断・治療
    　25．中條-西村症候群の概念・病態
    　26．中條-西村症候群の診断・鑑別診断・治療
    　27．点状紅斑の概念・病態・診断・治療
    　28．手掌紅斑の概念・病態・診断・治療　
    　29．symmetrical lividities of the soles of the feetの
    　　　　概念・病態・診断・治療　

    II　痒疹群
    　30．痒疹の定義・分類
    　31．痒疹発症における好塩基球の役割
    　32．急性痒疹・亜急性痒疹の概念・病態・症状
    　33．急性痒疹・亜急性痒疹の診断・治療・生活指導
    　34．慢性痒疹の定義・分類・症状・病理・診断・鑑別診断
    　35．慢性痒疹の病態と発症メカニズム　
    　36．慢性痒疹の痒みのメカニズム
    　37．慢性痒疹の臨床症状と必要な検査
    　38．慢性痒疹の疫学と労働生産性　
    　39.「慢性痒疹診療ガイドライン」の治療アルゴリズムと生活指導　
    　40．慢性痒疹の治療（1） 外用療法
    　41．慢性痒疹の治療（2） 全身療法　
    　42．慢性痒疹の治療（3） 紫外線療法　
    　43．慢性痒疹の治療（4） 活性型ビタミンＤ3療法　
    　44．色素性痒疹の概念・病態・診断・治療　
    　45．妊娠性痒疹とPUPPPの概念・病態・診断・治療　
    　46．妊娠に特異的な皮膚病変：atopic eruption of pregnancy
    　　　　（AEP)　―新たな疾患概念の位置づけ―　
    　47．デルマドロームとしての痒疹　　
    　48．金属アレルギーとしての痒疹　

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 紅斑症

P.2 掲載の参考文献
1) 西山茂夫. 環状の紅斑. 皮膚病診療 1979 ; 1 : 1101-4.
 
2) Katayama I, Asai T, Nishiyama S, et al. ICAM-1 and LFA-1 expressions in the lesional skin of annular erythema associated with Sjogren syndrome. J Dermatol 1990 ; 17 : 719-23.
PubMed
3) 片山一朗. 紅斑の分類と臨床検査・治療指針. MB Derma 2007 ; 122 : 1-5.
 
4) 片山一朗, 竹中基, 大仁田亜紀. サイトカイン, シグナル伝達阻害薬による皮膚障害. 玉置邦彦, ほか編. 最新皮膚科学大系 5. 薬疹・中毒疹. 東京 : 中山書店 ; 2004. pp168-74.
 
P.7 掲載の参考文献
1) Morita E, Schroder JM, Christophers E. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins. Scand J Immunol 1989 ; 29 : 709-16.
PubMed
2) Ying S, Robinson DS, Meng Q, et al. C-C chemokines in allergen-induced latephase cutaneous responses in atopic subjects : association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES). J Immunol 1999 ; 163 : 3976-84.
 
3) Mukai K, Matsuoka K, Taya C, et al. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 2005 ; 23 : 191-202.
PubMed
4) Miyazaki Y, Satoh T, Nishioka K, et al. STAT-6-mediated control of P-selectin by substance P and interleukin-4 in human dermal endothelial cells. Am J Pathol 2006 ; 169 : 697-707.
PubMed
5) Woltmann G, McNulty CA, Dewson G, et al. Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow. Blood 2000 ; 95 : 3146-52.
 
6) Andriopoulou P, Navarro P, Zanetti A, et al. Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler Thromb Vasc Biol 1999 ; 19 : 2286-97.
 
7) Niimi N, Noso N, Yamamoto S. The effect of histamine on cultured endothelial cells. A study of the mechanism of increased vascular permeability. Eur J Pharmacol 1992 ; 221 : 325-31.
PubMed
8) Yao L, Pan J, Setiadi H, et al. Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J Exp Med 1996 ; 184 : 81-92.
PubMed
9) Satoh T, Kaneko M, Wu MH, et al. Contribution of selectin ligands to eosinophil recruitment into the skin of patients with atopic dermatitis. Eur J Immunol 2002 ; 32 : 1274-81.
PubMed
10) Satoh T, Yokozeki H, Nishioka K. Pathogenic roles of eosinophils in guinea-pig contact sensitivity : regulation of dermal eosinophilia with remotely administered IL-5. Clin Exp Immunol 2000 ; 122 : 300-7.
PubMed
11) Bevilacqua MP, Pober JS, Mendrick DL, et al. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci U S A 1987 ; 84 : 9238-42.
PubMed
12) Litchfield TM, Smith CH, Atkinson BA, et al. Eosinophil infiltration into human skin is antigen-dependent in the late-phase reaction. Br J Dermatol 1996 ; 134 : 997-1004.
PubMed
13) Wakugawa M, Nakagawa H, Yamada N, et al. Chronologic analysis of eosinophil granule protein deposition and cell adhesion molecule expression in mite allergen-induced dermatitis in atopic subjects. Int Arch Allergy Immunol 1996 ; 111 Suppl 1 : 5-11.
 
14) Belmont HM, Buyon J, Giorno R, et al. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited. Arthritis Rheum 1994 ; 37 : 376-83.
PubMed
15) Rhodes LE, Joyce M, West DC, et al. Comparison of changes in endothelial adhesion molecule expression following UVB irradiation of skin and a human dermal microvascular cell line (HMEC-1). Photodermatol Photoimmunol Photomed 1996 ; 12 : 114-21.
 
16) Quinlan KL, Naik SM, Cannon G, et al. Substance P activates coincident NF-AT and NF-κB-dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization. J Immunol 1999 ; 163 : 5656-65.
 
17) Swerlick RA, Garcia-Gonzalez E, Kubota Y, et al. Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal microvascular endothelial cells. J Invest Dermatol 1991 ; 97 : 190-6.
PubMed
18) Katayama I, Asai T, Nishiyama S, et al. ICAM-1 and LFA-1 expressions in the lesional skin of annular erythema associated with Sjogren syndrome. J Dermatol 1990 ; 17 : 719-23.
PubMed
19) Kim YC, Bang D, Lee S, et al. The effect of herpesvirus infection on the expression of cell adhesion molecules on cultured human dermal microvascular endothelial cells. J Dermatol Sci 2000 ; 24 : 38-47.
 
20) Larcher C, Gasser A, Hattmannstorfer R, et al. Interaction of HSV-1 infected peripheral blood mononuclear cells with cultured dermal microvascular endothelial cells : a potential model for the pathogenesis of HSV-1 induced erythema multiforme. J Invest Dermatol 2001 ; 116 : 150-6.
PubMed
21) Bennion SD, Middleton MH, David-Bajar KM, et al. In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (ICAM-1) indicate different triggers of disease. J Invest Dermatol 1995 ; 105 (1 Suppl) : 71S-9S.
 
22) Swerlick RA, Lee KH, Li LJ, et al. Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. J Immunol 1992 ; 149 : 698-705.
PubMed
23) Quinlan KL, Song IS, Naik SM, et al. VCAM-1 expression on human dermal microvascular endothelial cells is directly and specifically up-regulated by substance P. J Immunol 1999 ; 162 : 1656-61.
PubMed
P.12 掲載の参考文献
1) Ackerman AB, Boer A, Bennin B, et al. Histologic Diagnosis of Inflammatory Skin Diseases. 3rd ed. New York : Ardor Scribendi ; 2005.
 
2) 木村鉄宣, ほか編. 最新皮膚科学大系 特別巻 3. 炎症性皮膚疾患の病理診断. 東京 : 中山書店 ; 2004.
 
P.19 掲載の参考文献
1) Fritsch PO, Ruiz-Maldonado R. Erythema multiforme. In : Freedberg IM, et al, editors. Dermatology in General Medicine. New York : McGraw-Hill ; 1999. pp626-44.
 
2) Stevens AM, Johnson FC. A new eruptive fever associated with stomatitis and ophthalmia. Am J Dis Child 1922 ; 24 : 526-33.
 
3) Thomas BA. The so-called Stevens-Johnson syndrome. Br Med J 1950 : 1 : 1393-7.
PubMed
4) Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995 ; 333 : 1600-7.
PubMed
5) 古江増隆, 山崎雙次, 神保孝一, ほか. 本邦における皮膚科受診患者の多施設横断四季別全国調査. 日皮会誌 2009 ; 119 : 1795-809.
 
6) Imafuku S, Kokuba H, Aurelian L, et al. Expression of herpes simplex virus DNA fragments located in epidermal keratinocytes and germinative cells is associated with the development of erythema multiforme lesions. J Invest Dermatol 1997 ; 109 : 550-6.
PubMed
P.24 掲載の参考文献
1) Schmidt H. Isolation of herpes simplex virus from blisters of a patient with Stevens-Johnson's syndrome. Acta Derm Venereol 1961 ; 41 : 53-5.
 
2) Major PP, Morisset R, Kurstak C, et al. Isolation of herpes simplex virus type 1 from lesions of erythema multiforme. Can Med Assoc J 1978 ; 118 : 821-2.
PubMed
3) Macdonald A, Feiwel M. Isolation of herpes virus from erythema multiforme. Br Med J 1972 ; 2 : 570-1.
PubMed
4) Foerster DW, Scott LV. Isolation of herpes-simplex virus from a patient with erythema multiforme exudativum (Stevens-Johnson syndrome). N Engl J Med 1958 ; 259 : 473-5.
PubMed
5) Orton PW, Huff JC, Tonnesen MG, et al. Detection of a herpes simplex viral antigen in skin lesions of erythema multiforme. Ann Intern Med 1984 ; 101 : 48-50.
PubMed
6) Kazmierowski JA, Peizner DS, Wuepper KD. Herpes simplex antigen in immune complexes of patients with erythema multiforme : presence following recurrent herpes simplex infection. JAMA 1982 ; 247 : 2547-50.
PubMed
7) Brice SL, Krzemien D, Weston WL, et al. Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme. J Invest Dermatol 1989 ; 93 : 183-7.
PubMed
8) Sun Y, Chan RK, Tan SH, et al. Detection and genotyping of human herpes simplex viruses in cutaneous lesions of erythema multiforme by nested PCR. J Med Virol 2003 ; 71 : 423-8.
PubMed
9) Ng PP, Sun YJ, Tan HH, et al. Detection of herpes simplex virus genomic DNA in various subsets of erythema multiforme by polymerase chain reaction. Dermatology 2003 ; 207 : 349-53.
PubMed
10) Miura S, Smith CC, Burnett JW, et al. Detection of viral DNA within skin of healed recurrent herpes simplex infection and erythema multiforme lesions. J Invest Dermatol 1992 ; 98 : 68-72.
PubMed
11) Aslanzadeh J, Helm KF, Espy MJ, et al. Detection of HSV-specific DNA in biopsy tissue of patients with erythema multiforme by polymerase chain reaction. Br J Dermatol 1992 ; 126 : 19-23.
 
12) Ono F, Sharma BK, Smith CC, et al. CD34+ cells in the peripheral blood transport herpes simplex virus DNA fragments to the skin of patients with erythema multiforme (HAEM). J Invest Dermatol 2005 ; 124 : 1215-24.
 
13) Imafuku S, Kokuba H, Aurelian L, et al. Expression of herpes simplex virus DNA fragments located in epidermal keratinocytes and germinative cells is associated with the development of erythema multiforme lesions. J Invest Dermatol 1997 ; 109 : 550-6.
PubMed
14) Kokuba H, Imafuku S, Huang S, et al. Erythema multiforme lesions are associated with expression of a herpes simplex virus (HSV) gene and qualitative alterations in the HSV-specific T-cell response. Br J Dermatol 1998 ; 138 : 952-64.
PubMed
15) Kokuba H, Imafuku S, Burnett JW, et al. Longitudinal study of a patient with herpes-simplex-virus-associated erythema multiforme : viral gene expression and T cell repertoire usage. Dermatology 1999 ; 198 : 233-42.
 
16) Foy HM, Nolan CM, Allan ID. Epidemiologic aspects of M. pneumoniae disease complications : a review. Yale J Biol Med 1983 ; 56 : 469-73.
PubMed
17) Kunimi Y, Hirata Y, Aihara M, et al. Statistical analysis of Stevens-Johnson syndrome caused by Mycoplasma pneumonia infection in Japan. Allergol Int 2011 ; 60 : 525-32.
 
18) Tay YK, Huff JC, Weston WL. Mycoplasma pneumoniae infection is associated with Stevens-Johnson syndrome, not erythema multiforme (von Hebra). J Am Acad Dermatol 1996 ; 35 : 757-60.
PubMed
19) Khan FY, A yassin M. Mycoplasma pneumoniae associated with severe autoimmune hemolytic anemia : case report and literature review. Braz J Infect Dis 2009 ; 13 : 77-9.
PubMed
20) Li K, Haber RM. Stevens-Johnson syndrome without skin lesions (Fuchs syndrome) : a literature review of adult cases with Mycoplasma cause. Arch Dermatol 2012 ; 148 : 963-4.
PubMed
21) Ruocco E, Lo Schiavo A, Baroni A, et al. Pemphigus vulgaris after coxsackievirus infection and cephalosporin treatment : a paraviral eruption? Dermatology 2008 ; 216 : 317-9.
PubMed
22) Kacar N, Cevahir N, Demirkan N, et al. The investigation of the possible relationship between Coxsackie viruses and pemphigus. Int J Dermatol 2013. [Epub ahead of print]
 
23) Friedman SJ, Perry HO. Erythema multiforme associated with contact dermatitis. Contact Dermatitis 1985 ; 12 : 21-3.
PubMed
24) Contreras-Barrera ME, Moreno-Coutino G, Torres-Guerrero DE, et al. Erythema multiforme secondary to cutaneous Trichophyton mentagrophytes infection. Rev Iberoam Micol 2009 ; 26 : 149-51.
PubMed
25) Ilkit M, Durdu M, Karakas M. Cutaneous id reactions : a comprehensive review of clinical manifestations, epidemiology, etiology, and management. Crit Rev Microbiol 2012 ; 38 : 191-202.
PubMed
26) Vitiello M, Echeverria B, Elgart G, et al. Erythema multiforme major associated with CMV infection in an immunocompetent patient. J Cutan Med Surg 2011 ; 15 : 115-7.
 
27) Cieza-Diaz DE, Campos-Dominguez M, Santos-Sebastian MD, et al. Erythema multiforme in a newborn associated with acute acquired cytomegalovirus infection. Pediatr Dermatol 2013 ; 30 : e161-3.
 
28) Huang H, Kamijima M, Wang H, et al. Human herpesvirus 6 reactivation in trichloroethylene-exposed workers suffering from generalized skin disorders accompanied by hepatic dysfunction. J Occup Health 2006 ; 48 : 417-23.
PubMed
P.30 掲載の参考文献
1) 塩原哲夫. 重症薬疹の診断基準. 西間三馨, 監修. アレルギー性疾患診断・治療ガイドライン 2010. 東京 : 協和企画 ; 2010. pp236-301.
 
2) Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome and erythema multiforme. Arch Dermatol 1993 ; 129 : 92-6.
PubMed
3) Viard I, Wehrli P, French LE. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998 ; 282 : 490-3.
PubMed
4) Narita YM, Hirahara K, Mizukawa Y, et al. Efficacy of plasmapheresis for the treatment of severe toxic epidermal necrolysis : is cytokine expression analysis useful in predicting its therapeutic efficacy? J Dermatol 2011 ; 38 : 236-45.
PubMed
5) Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS) : a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 2006 ; 55 : 1-8.
PubMed
6) Shiohara T, Kano Y, Takahashi R, et al. Drug-induced hypersensitivity syndrome : recent advances in the diagnosis, pathogenesis and management. In : French LE, editor. Adverse Cutaneous Drug Eruptions. Chemical Immunology and Allergy Vol.97. Basel : Karger ; 2012. pp122-38.
 
7) Suzuki Y, Inagi R, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998 ; 134 : 1108-12.
PubMed
8) Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypoglobulinemia. Arch Dermatol 2004 ; 40 : 226-30.
 
9) Asano Y, Kagawa H, Kano Y, et al. Cytomegalovirus disease during severe drug eruptions : report of 2 cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome. Arch Dermatol 2009 ; 145 : 1030-6.
PubMed
P.39 掲載の参考文献
1) Huff JC, Weston WL, Tonnesen MG. Erythema multiforme : a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 1983 ; 8 : 763-75.
PubMed
2) Sokumbi O, Wetter DA. Clinical features, diagnosis, and treatment of erythema multiforme : a review for the practicing dermatologist. Int J Dermatol 2012 ; 51 : 889-902.
PubMed
3) 渡辺秀晃. 多形滲出性紅斑. 今日の皮膚疾患治療指針. 第4版. 東京 : 医学書院 ; 2012. pp345-7.
 
4) Weston WL. Herpes-associated erythema multiforme. J Invest Dermatol 2005 ; 124 : xv-xvi.
PubMed
5) Schalock PC, Dinulos JG, Pace N, et al. Erythema multiforme due to Mycoplasma pneumoniae infection in two children. Pediatr Dermatol 2006 ; 23 : 546-55.
PubMed
6) French LE, Prins C. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. In : Bolognia JL, et al, editors. Dermatology. 2nd ed. Vol.1. St Louis : Mosby Elsevier ; 2008. pp287-300.
 
7) Hosaka H, Ohtoshi S, Nakada T, et al. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis : frozen-section diagnosis. J Dermatol 2010 ; 37 : 407-12.
PubMed
8) Wetter DA, Davis MD. Recurrent erythema multiforme : clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007. J Am Acad Dermatol 2010 ; 62 : 45-53.
 
P.44 掲載の参考文献
1) 永井弥生. 女性の結節性紅斑とは? 宮地良樹, 編. 女性の皮膚トラブル FAQ. 東京 : 診断と治療社 ; 2012. pp302-8.
 
2) Cribier B, Caille A, Heid E, et al. Erythema nodosum and associated diseases. A study of 129 cases. Int J Dermatol 1998 ; 37 : 667-73.
 
3) Salvatore MA, Lynch PJ. Erythema nodosum, estrogens, and pregnancy. Arch Dermatol 1980 ; 116 : 557-9.
PubMed
4) Jorgenson KT, Pedersen BV, Nielsen NM, et al. Childbirth and risk of female predominant and other autoimmune diseases in a population-based Danish cohort. J Autoimmunity 2011 ; 38 : 1-7.
 
5) 勝岡憲生, 佐藤勘治. 結節性紅斑の多様性. MB Derma 2007 ; 122 : 65-72.
 
6) 森澤有希, 武藤潤, 若松慶太, ほか. 結節性紅斑-マイコプラズマ感染症に併発した症例. 皮膚病診療 2007 ; 29 : 919-22.
 
7) 西薫, 中村哲史, 橋本善夫, ほか. 肝酵素上昇を伴ったマイコプラズマ感染による結節性紅斑. 臨床皮膚科 2009 ; 63 : 501-4.
 
8) 満山陽子, 平原和久, 狩野葉子, ほか. マイコプラズマ感染症との関連が示唆された結節性紅斑. 皮膚科の臨床 2005 ; 47 : 1219-23.
 
9) Castriota M, Ricci F, Paradisi A, et al. Erythema nodosum induced by kerion celsi of the scalp in a child : a case report and mini-review of literature. Mycoses 2013 ; 56 : 200-3.
 
10) Psychos DN, Voulgari PV, Skopouli FN, et al. Erythema nodosum : the underlying conditions. Clin Rheumatol 2000 ; 19 : 212-6.
 
11) Bombardieri S, Munno OD, Punzio C, et al. Erythema nodosum associated with pregnancy and oral contraceptives. Br Med J 1977 ; 1 : 1509-10.
PubMed
12) 山崎雙次. 結節性紅斑. 玉置邦彦, ほか編. 最新皮膚科学大系 4. 紅斑・滲出性紅斑 紫斑 脈管系の疾患. 東京 : 中山書店 ; 2003. pp11-5.
 
13) Nakamura T, Yoshioka K, Miyashita T, et al. Granulomatous mastitis complicate by arthralgia and erythema nodosum successfully treated with prednisolone and methotrexate. Intern Med 2012 ; 51 : 2957-60.
PubMed
14) 三原清香, 曽我部陽子, 永井弥生, ほか. 肉芽腫性乳腺炎に伴った結節性紅斑の1例. 臨床皮膚科 2007 ; 61 : 510-3.
 
P.48 掲載の参考文献
1) 溝口昌子. Behcet病. 玉置邦彦, ほか編. 最新皮膚科学大系 4. 紅斑・滲出性紅斑紫斑 脈管の疾患. 東京 : 中山書店 ; 2003. pp221-32.
 
2) 岡本祐之. サルコイドーシスの皮膚病変. 診断と治療 2011 ; 99 : 104-13.
Medical*Online
3) Okamoto H, Mizuno K, Imamura S, et al. Erythema nodosum-like eruption in sarcoidosis. Clin Exp Dermatol 1994 ; 19 : 507-10.
 
4) 狩野葉子. クローン病の皮膚病変. G. I. Research 2006 ; 14 : 77-81.
Medical*Online
5) 山本俊幸. 潰瘍性大腸炎に併発した結節性紅斑および壊疽性膿皮症の各1例. 臨床皮膚科 1993 ; 47 : 569-73.
 
6) 金子健彦. 皮膚病変からみる消化器疾患. MB Derma 2009 ; 150 : 6-11.
 
7) 伊崎誠一. うっ滞性症候群. 玉置邦彦, ほか編. 最新皮膚科学大系 4. 紅斑・滲出性紅斑 紫斑 脈管の疾患. 東京 : 中山書店 ; 2003. pp201-8.
 
8) 田中亜紀, 古川福実. Cytophagic histiocytic panniculitis (CHP) および反応性血球貪食. 瀧川雅浩, ほか編. 新・皮膚悪性リンパ腫アトラス. 東京 : 文光堂 ; 2006. pp158-9.
 
P.54 掲載の参考文献
1) Bazin E. Lecons theoriques et cliniques sur la scrofule. 2nd ed. Paris : A. Delahaye ; 1861. p146.
 
2) Montgomery H, O'Leary PA, Barker NW. Nodular vascular diseases of the legs : erythema induratum and allied conditions. JAMA 1945 ; 128 : 335-45.
 
3) McNutt NS, Moreno A, Contreras F. Erythema induratum (nodular vasculitis). In : Elder DE, et al, editors. Lever's Histopathology of the Skin. 10th ed. Philadelphia : Lippincott Williams & Wilkins ; 2008. pp519-21.
 
4) 新見やよい, 落合廣武, 本田光芳, ほか. 日本医科大学付属病院皮膚科における60年間の皮膚結核の統計. 日皮会誌 2008 ; 118 : 1095-100.
 
5) 久保田愛, 高橋英至, 上田暢彦, ほか. 結節性紅斑様病変を呈したBazin硬結性紅斑. 皮膚病診療 2010 ; 32 : 263-6.
 
6) 太居英夫. サーモグラフィーによる下腿循環の研究. 皮膚 1980 ; 22 : 532-49.
 
7) Parish WE, Rhodes EL. Bacterial antigen and aggregated gamma globulin in the lesion of nodular vasculitis. Br J Dermatol 1967 ; 79 : 131-47.
PubMed
8) 高松紘子, 池上隆太, 猿喰浩子, ほか. QuantiFERON(R) を用いて検討したバザン硬結性紅斑の1例. 皮膚の科学 2006 ; 5 : 239-44.
 
9) 堀米玲子, 松本和彦. Bazin硬結性紅斑. 皮膚病診療 2005 ; 27 : 365-8.
 
10) Segura S, Pujol RM, Trindade F, et al. Vasculitis in erythema induratum of Bazin : a histopathologic study of 101 biopsy specimens from 86 patients. J Am Acad Dermatol 2008 ; 59 : 839-51.
 
11) 中村晃一郎. 結節性紅斑と鑑別となる皮膚疾患. 日皮会誌 2007 ; 117 : 1287-94.
 
12) 日本結核病学会予防委員会. クォンティフェロン(R) TBゴールドの使用指針. 結核 2011 ; 86 : 839-44.
Medical*Online
13) 安彦忠之, 猪狩英俊, 小栗豊子, ほか. 潜在性結核感染症. 日本結核病学会, 編. 結核診療ガイドライン. 改訂第2版. 東京 : 南江堂 ; 2009. pp93-109.
 
14) 澁谷真貴子, 寺木祐一. クオンティフェロン検査と皮膚結核. 臨床皮膚科 2009 ; 63 Suppl 5 : 65-8.
 
15) 田辺恵美子. Bazin硬結性紅斑の変遷-最近の症例も含めて. 皮膚病診療 2000 ; 22 : 806-12.
 
16) 小西研史, 森田和政, 高橋健造, ほか. 頸部リンパ節結核を伴ったBazin硬結性紅斑の1例. 臨床皮膚科 2002 ; 56 : 658-60.
 
17) Yagi M, Kawabata I, Izaki S, et al. Primary tuberculosis of the nasopharynx with erythema induratum of Bazin. ORL J Otorhinolaryngol Relat Spec 1994 ; 56 : 291-4.
PubMed
18) 高橋学位. Bazin硬結性紅斑 PCR法で抗酸菌陽性だった1例. 日皮会誌 1998 ; 108 : 1300.
 
19) 加藤則人. 結節性紅斑と類症 (鑑別診断を含む). 日皮会誌 2008 ; 118 : 2403-6.
 
20) 中村晃一郎. 結節性紅斑と鑑別となる皮膚疾患. 日皮会誌 2007 ; 117 : 1287-94.
 
21) 齊藤典充. 皮膚アレルギー性血管炎 (Ruiter) の診断と治療. 勝岡憲生, ほか編. 皮膚科臨床アセット 5. 皮膚の血管炎・血行障害. 東京 : 中山書店 ; 2011. pp138-42.
 
22) Lindberg K. A contribution to the knowledge of periarteritis nodosa. J Intern Med 1931 ; 76 : 183-225.
 
23) 日本結核病学会治療委員会. 「結核医療の基準」の見直し-2008年. 結核 2008 ; 83 : 529-35.
 
P.59 掲載の参考文献
1) El Fekih N, Belgith I, Fazaa B, et al. Erythema elevatum diutinum : an "idiopathic" case. Dermatology Online Journal 2011 ; 17 : 7.
PubMed
1) Hutchinson J. On two remarkable cases of symmetrical purple congestion of the skin in patches, with induration. Br J Dermatol 1888 ; 1 : 10-5.
 
2) Bury JS. A case of erythema with remarkable nodular thickening and induration of the skin associated with intermittent albuminuria. Illus Med News 1889 ; 3 : 145-7.
 
3) Radcliffe-Crocker H, Williams C. Erythema elevatum diutinum. Br J Dermatol 1894 ; 6 : 33-8.
 
4) 塩入有子, 松吉徳久, 戸田憲一, ほか. 持久性紅斑の1例. 皮膚科紀要 1998 ; 93 : 593-8.
 
5) Ly H, Black MM. Atypical presentation of erythema elevatum diutinum. Australas J Dermatol 2005 ; 46 : 44-6.
PubMed
6) 木村恭一, 河合公三. 潰瘍性大腸炎にみられた持久性隆起性紅斑. 皮膚科の臨床 2002 ; 44 : 159-63.
 
7) 柿木須賀子, 佐々木富美子, 尾高達雄, ほか. IgA-κ型M蛋白血症を伴った持久性隆起性紅斑. 皮膚 1988 ; 30 : 341-7.
 
8) 稲田めぐみ, 石河晃. IgA-λ型M蛋白血症を伴った持久性隆起性紅斑. 皮膚病診療 1997 ; 19 : 999-1002.
 
9) Yiannias JA, el-Azhary RA, Gibson LE. Erythema elevatum diutinum : a clinical and histopathological study of 13 patients. J Am Acad Dermatol 1992 ; 26 : 38-44.
PubMed
10) Ayoub N, Charuel JL, Diemert MC, et al. Antineutrophil cytoplasmic antibodies of IgA class in neutrophilic dermatoses with emphasis on erythema elevatum diutinum. Arch Dermatol 2004 ; 140 : 931-6.
PubMed
11) Wahl CE, Bouldin MB, Gibson LE. Erythema elevatum diutinum : clinical, histopathologic, and immunohistochemical characteristics of six patients. Am J Dermatopathol 2005 ; 27 : 397-400.
PubMed
12) Sachdev DS, Kharkar VD, Mahajan SA, et al. Erythema elevatum diutinum. J Postgrad Med 2002 ; 48 : 310-1.
PubMed
13) Rosa DJ, Machado RF, Fraga Rde O, et al. Erythema elevatum diutinum as a differential diagnosis of rheumatic diseases : case report. Rev Bras Reumatol 2012 ; 52 : 291-4.
PubMed
14) Kohler IK, Lorincs AL. Erythema elevatum diutinum treated with niacinamide and tetracycline. Arch Dermatol 1980 ; 116 : 693-5.
 
15) Wilkinson SM, English JS, Smith NP, et al. Erythema elevatum diutinum : a clinicopathological study. Clin Exp Dermatol 1992 ; 17 : 87-93.
PubMed
16) Henriksson R, Hofer PA, Hornqvist R. Erythema elevatum diutinum-a case successfully treated with colchicine. Clin Exp Dermatol 1989 ; 14 : 451-3.
PubMed
17) Roenigk HH Jr. Necrotizing vasculitis (erythema elevatum diutinum). Arch Dermatol 1971 ; 104 : 103-5.
PubMed
18) Chow RK, Benny WB, Coupe RL, et al. Erythema elevatum diutinum associated with IgA paraproteinemia successfully controlled with intermittent plasma exchange. Arch Dermatol 1996 ; 132 : 1360-4.
PubMed
19) 井村倫子, 伊藤明子, 坂本ふみ子, ほか. 十二指腸潰瘍のHelicobacter pylori除菌療法後に著明な軽快をみた持久性隆起性紅斑の1例. 臨床皮膚科 2007 ; 61 : 417-20.
 
P.63 掲載の参考文献
1) Kawakami T, Ohashi S, Kawa Y, et al. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of Sweet syndrome and patients with active Behcet disease : implication in neutrophil apoptosis dysfunction. Arch Dermatol 2004 ; 140 : 570-4.
PubMed
1) 川上民裕. 皮膚病変からとらえる膠原病-皮膚科からの逆襲. Behcet病/Sweet病/壊疽性膿皮症. MB Derma 2011 ; 176 : 80-5.
 
2) 溝口昌子. Sweet病. 日臨免誌 1996 ; 19 : 169-78.
 
3) Kawakami T, Kawase A, Takeuchi S, et al. Sweet syndrome subsequent to relapsing polychondritis and myelodysplastic syndrome in a Japanese patient. Acta Derm Venereol 2008 ; 88 : 517-9.
 
4) Cohen PR, Talpaz M, Kurzrock R. Malignancy-associated Sweet's syndrome : review of the world literature. J Clin Oncol 1988 ; 6 : 1887-97.
PubMed
P.69 掲載の参考文献
1) 中村晃一郎. ベーチェット病. 今日の治療指針. 東京 : 医学書院 ; 2010. pp970-1.
 
2) 黒澤美智子, 稲葉裕, 石ケ坪良明, ほか. ベーチェット病の新規受給者の1年, 5年後の予後. 厚生労働科学研究費補助金 (難治性疾患克服研究事業) 研究報告書 ベーチェット病に関する調査研究 平成23年度総括・分担研究報告書. 2012. pp56-60.
 
3) 黒澤美智子. ベーチェット病の疫学. 日眼会誌 2011 ; 116 : 402-5.
 
4) 稲葉裕. ベーチェット病全国疫学調査-臨床疫学像. 厚生労働科学研究費補助金 (難治性疾患克服研究事業) 研究報告書 ベーチェット病に関する調査研究 平成16年度総括・分担研究報告書. 2005. pp91-4.
 
5) 黒澤美智子, 稲葉裕, 石ケ坪良明, ほか. 特殊型ベーチェット病 (腸管型, 血管型, 神経型) の臨床疫学像. 厚生労働科学研究費補助金 (難治性疾患克服研究事業) 研究報告書 ベーチェット病に関する調査研究 平成21年度総括・分担研究報告書. 2010. pp60-5.
 
6) Mizuki N, Meguro A, Ota M, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat Genet 2010 ; 42 : 703-6.
PubMed
7) 石ケ坪良明, 寒川整, 桐野洋平, ほか. ベーチェット病とインフラマソームに関する研究. 厚生労働科学研究費補助金 (難治性疾患克服研究事業) 研究報告書 ベーチェット病に関する調査研究 平成22年度総括・分担研究報告書. 2011. pp108-12.
 
8) Horie Y, Meguro A, Ota M, et al. Association of TLR4 polymorphisms with Behcet's disease in a Korean population. Rheumatology 2009 ; 48 : 638-42.
 
9) Meguro A, Ota M, Katsuyama Y, et al. Association of the toll-like receptor 4 gene polymorphisms with Behcet's disease. Ann Rheum Dis 2008 ; 67 : 725-7.
PubMed
10) Chen X, Katoh Y, Nakamura K, et al. Single nucleotide polymorphisms of Ficolin 2 gene in Behcet's disease. J Dermatol Sci 2006 ; 43 : 201-5.
PubMed
11) Wang H, Nakamura K, Inoue T, et al. Mannose-binding lectin polymorphisms in patients with Behcet's disease. J Dermatol Sci 2004 ; 36 : 115-7.
PubMed
12) Shimizu J, Takai K, Fujiwara N, et al. Excessive CD4+T cells co-expressing interleukin-17 and interferon-γ in patients with Behcet's disease. Clin Exp Immunol 2012 ; 168 : 68-74.
 
13) Kirino Y, Takeno M, Watanabe R, et al. Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behcet's disease. Arthritis Res Ther 2008 ; 10 : R16.
PubMed
14) Yanagihori H, Oyama N, Nakamura K, et al. Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility : an involvement of Th1 immunoreactivity against Streptococcus sanguinis antigen. J Invest Dermatol 2006 ; 126 : 1534-40.
PubMed
15) Kaneko F, Togashi A, Saito S, et al. Behcet disease. Clin Dev Immunol 2011 ; 2011 : 681956.
PubMed
16) Kaneko F, Togashi A, Nomura E, et al. Role of heat shock protein derived from Streptococcus sanguinis in Behcet's disease. J Medical Microbil Diagnosis 2012 ; S2 : 001.
 
17) 中村晃一郎, 宮野恭平, 金子史男. ベーチェット病の自然免疫に関する研究. 厚生労働科学研究費補助金 (難治性疾患克服研究事業) 研究報告書 ベーチェット病に関する調査研究 平成24年度総括・分担研究報告書. 2013. pp51-2.
 
P.75 掲載の参考文献
1) Sakane T, Takeno M, Suzuki N, et al. Behcet's disease. N Engl J Med 1999 ; 341 : 1284-91.
PubMed
2) Shimizu J, Takai K, Fujiwara N, et al. Expressive CD4+T cells co-expressing interleukin-17 and interferon-γ in patients with Behcet's disease. Clin Exp Immunol 2012 ; 168 : 68-74.
 
3) Shimizu J, Izumi T, Arimitsu N, et al. Skewed TGFβ/Smad signalling pathway of T cells in patients with Behcet's disease. Clin Exp Rheumatol 2012 ; 30 (3 Suppl 72) : S35-9.
 
4) Isogai E, Ohno S, Takashi K, et al. Close association of Streptococcus sanguis uncommon serotypes with Behcet's disease. Bifidobact Microflora 1990 ; 9 : 27-41.
 
5) Isogai E, Ohno S, Kotake S, et al. Chemiluminescence of neutrophils from patients with Behcet's disease and its correlation with increased proportion of uncommon serotype of Streptococcus sanguis in the oral flora. Arch Oral Biol 1990 ; 272 : 36-46.
 
6) Behcet H. Uber rezidivierende, aphthose durch ein Virus verursachte Geschwuere am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 1937 ; 105 : 1152-7.
 
7) Tojo M, Zheng X, Yanagihori H, et al. Detection of herpes virus genomes in skin lesions from patients with Behcet's disease and other related inflammatory diseases. Acta Derm Venereol 2003 ; 83 : 124-7.
PubMed
8) Graykowski EA, Bariele MF, Boyd LW, et al. Recurrent aphthous stomatitis : clinical therapeutic and histologic and hypersensitivity aspects. JAMA 1966 ; 196 : 637-44.
 
9) Mizushima Y (The Behcet's Disease Research Committee of Japan). Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behcet's disease. J Rheumatol 1989 ; 16 : 506-11.
 
10) Kaneko F, Oyama N, Nishibu A. Streptococcal infection in the pathogenesis of Behcet's disease and clinical factors of minocycline on the disease symptoms. Yonsei Med J 1997 ; 38 : 444-54.
 
11) Yanagihori H, Oyama N, Nakamura K, et al. Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility : an involvement of Th1 immunoreactivity against Streptococcus sanguinis antigen. J Invest Dermatol 2006 ; 126 : 1534-40.
PubMed
12) Yoshikawa K, Kotake S, Kubota T, et al. Cloning and sequencing of Bes-1 gene encoding the immunogenic antigen of Streptococcus sanguis KTH-1 isolated from the patients with Behcet's disease. Zentral bl Bakteriol 1998 ; 287 : 449-60.
 
13) Tojo M, Yanagihori H, Zheng X, et al. Bes-1 DNA fragment encoding Streptococcal antigen in skin lesions from patients with Behcet's disease. J Appl Res 2003 ; 3 : 232-8.
 
14) Isogai E, Isogai H, Kotake S, et al. Role of Streptococcus sanguis and traumatic factors in Behcet's disesase. J Appl Res 2003 ; 3 : 64-75.
 
15) Yamashita N, Kaneko S, Takeno M, et al. Role of γδT lymphocytes in the development of Behcet's disease. Clin Exp Immunol 1997 ; 107 : 241-7.
 
16) Kaneko F, Takahashi Y, Muramatsu R, et al. Natural killer cell numbers and function in peripheral lymphoid cells in Behcet's disease. Br J Dermatol 1985 ; 113 : 313-8.
PubMed
17) Pervin K, Childerstone A, Shinnick T, et al. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behcet's disease. J Immunol 1993 ; 151 : 2273-82.
PubMed
18) Cho SB, Ahn KJ, Kim DH, et al. Identification of HnRNP-A2/B1 as a target antigen of anti-endothelial cell IgA antibody in Behcet's disease. J Invest Dermatol 2012 ; 132 : 601-8.
PubMed
19) Kaneko F, Oyama N, Yanagihori H, et al. The role of streptococcal hypersensitivity in pathogenesis of Behcet's disease. Eur J Dermatol 2008 ; 18 : 489-98.
PubMed
20) Kaneko F, Togashi A, Saito S, et al. Behcet's disease (Adamantiades-Behcet's disease). Clin Dev Immunol 2011 ; 2011 : 681956.
PubMed
P.81 掲載の参考文献
1) ベーチェット病に関する調査研究班. ベーチェット病. 疾病対策研究会, 編. 難病の診断と治療指針 1. 第3版. 東京 : 東京六法出版 ; 2005. pp1-16.
 
2) International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990 ; 335 : 1078-80.
 
3) Ohno S, Ohguchi M, Hirose S, et al. Close association of HLA-Bw51 with Behcet's disease. Arch Ophthalmol 1982 ; 100 : 1455-8.
PubMed
4) Sakane T, Takeno K, Suzuki N, et al. Behcet's disease. N Engl J Med 1999 ; 341 ; 1284-91.
 
5) Davachi F, Chams-Davachi C, Sharam F, et al. Pathergy test in Behcet's disease : change in incidence over the time. J Rheumatol 2007 ; 10 : 333-5.
 
6) Fresko I, Yazici H, Bayramicli M, et al. Effect of surgical cleaning of the skin on the pathergy phenomenon in Behcet's syndrome. Ann Rheum Dis 1993 ; 52 : 619-20.
PubMed
7) Alpsoy E, Ozlem Elpeck G, Yilmaz F, et al. Androgen receptor levels of oral and genital ulcers and skin pathergy test in patients with Behcet's disease. Dermatology 2005 ; 210 : 31-5.
 
8) 金子史男, 齋藤早苗, 富樫亜吏, ほか. ベーチェット病の補助診断法としての自家唾液によるプリック反応. 日皮会誌 2010 ; 120 : 1901-5.
 
9) Togashi A, Saito S, Kaneko F, et al. Skin prick test with self-saliva in patients with oral aphthoses : a new diagnostic pathergy for Behcet's disease and recurrent aphthosis. Inflamm Allergy Drug Targets 2011 ; 10 : 164-70.
PubMed
10) Jurge S, Kuffer R, Scully C, et al. Mucosal disease series. Number VI. Recurrent aphthous stomatitis. Oral Dis 2006 ; 12 : 1-21.
PubMed
11) Sweet RD. An acute febrile dermatosis. Br J Dermatol 1964 ; 76 : 349-56.
PubMed
12) Kemmett D, Hunter JAA. Sweet's syndrome : a clinicopathologic review of twenty-nine cases. J Am Acad Dermatol 1990 ; 23 : 503-7.
 
13) 金子史男. Sweet病. Behcet病. 玉置邦彦, ほか編. 最新皮膚科学大系 4. 紅斑・滲出性紅斑 紫斑 脈管系の疾患. 東京 : 中山書店 ; 2003. pp33-51.
 
14) Otsuka M, Iwatsuki K, Kaneko F. Pyoderma gangrenosum associated with chronic myeloid leukemia. Eur J Dermatol 1996 ; 6 : 73-4.
 
15) Kaneko F, Ito S, Nagai M. A case of Weber-Christian disease suggesting cell immunodeficiency. J Dermatol 1975 ; 2 : 137-41.
 
16) Hojo N, Hasegawa H, Iwamasa K, et al. A case of Weber-Christian disease associated with myelodysplastic syndrome. Mod Rheumatol 2004 ; 14 : 73-6.
PubMed
17) Schwartz T, Langevitz P, Zemer D, et al. Behcet's disease in familial Mediterranean fever : characterization of the association between the two diseases. Semin Arthritis Rheum 2000 ; 29 : 286-95.
PubMed
18) Migita K, Uehara R, Nakamura Y, et al. Familial Mediterranean fever in Japan. Medicine 2012 ; 91 : 337-43.
PubMed
19) Masuda K, Urayama A, Kogure M, et al. Double masked trial of cyclosporine versus colchicine and long term open study of cyclosporine in Behcet's disease. Lancet 1989 ; 1 : 1093-6.
PubMed
20) Kaneko F, Oyama N, Nishibu A. Streptococcal infection in the pathogenesis of Behcet's disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J 1997 ; 38 : 444-54.
PubMed
21) Accorinti M, Pirragli MP, Pariori R, et al. Infliximab treatment for ocular and extraocular manifestations of Behcet's disease. Jpn J Ophthalmol 2007 ; 51 : 191-6.
 
P.86 掲載の参考文献
1) Yamamoto T. Cutaneous manifestations associated with rheumatoid arthritis. Rheumatol Int 2009 ; 29 : 979-88.
PubMed
2) Bremner R, Simpson E, White Jr CR, et al. Palisaded neutrophilic and granulomatous dermatitis : an unusual cutaneous manifestation of immune-mediated disorders. Semin Arthritis Rheum 2004 ; 34 : 610-6.
 
3) Stephenson SR, Campbell SM, Drew GS, et al. Palisaded neutrophilic and granulomatous dermatitis presenting in a patient with rheumatoid arthritis on adalimumab. J Cutan Pathol 2011 ; 38 : 644-8.
 
4) 前賢一郎, 斎藤万寿吉, 斎藤麿美, ほか. リンパ管内組織球症. 皮膚病診療 2012 ; 34 : 720-5.
 
P.91 掲載の参考文献
1) Cho YT, Liao YH. Prurigo pigmentosa-like persistent papules and plaques in a patient with adult-onset Still's disease. Acta Derm Venereol 2013. [Epub ahead of print]
 
2) Moraites E, Myers DJ, Lloyd R, et al. A 38-year-old woman with eyelid discoloration. Heliotrope-like manifestation of adult-onset Still disease (AOSD). Arch Dermatol 2012 ; 148 : 947-52.
 
3) Ohashi M, Moriya C, Kanoh H, et al. Adult-onset Still's disease with dermatomyositis-like eruption. J Dermatol 2012 ; 39 : 958-60.
PubMed
4) Lee JY, Yang CC, Hsu MM. Histopathology of persistent papules and plaques in adult-onset Still's disease. J Am Acad Dermatol 2005 ; 52 : 1003-8.
PubMed
5) Colafrancesco S, Priori R, Alessandri C, et al. IL-18 serum level in adult onset Still's disease : a marker of disease activity. Int J Inflam 2012 ; 2012 : 156890.
PubMed
6) Wolgamot G, Yoo J, Hurst S, et al. Unique histopathologic findings in a patient with adult-onset Still disease. Am J Dermatopathol 2007 ; 49 : 194-6.
 
7) Woods MT, Gavino AC, Burford HN, et al. The evolution of histopathologic findings in adult Still disease. Am J Dermatopathol 2011 ; 33 : 736-9.
PubMed
8) Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992 ; 19 : 424-30.
 
9) Ohta A, Matsumoto Y, Ohta T. Still's disease associated with necrotizing lymphadenitis (Kikuchi's disease) : report of 3 cases. J Rheumatol 1998 ; 15 : 981-3.
 
10) Yamamoto T. Cutaneous manifestations associated with adult-onset Still's disease : important diagnostic values. Rheumatol Int 2012 ; 32 : 2233-7.
PubMed
P.98 掲載の参考文献
1) 竹中祐子, 林伸和. 環状紅斑. 日皮会誌 2008 ; 118 : 2407-14.
 
2) 宮川幸子. 環状紅斑の病態と分類 20世紀の総括. 西日皮膚 2001 ; 63 : 3-7.
 
3) 飯塚一. 環状皮疹のメカニズム. Visual Dermatology 2005 ; 4 : 123.
 
4) 今山修平. 遠心性環状紅斑. Visual Dermatology 2005 ; 4 : 128-30.
 
5) Darier J. De l'erytheme annulaire centrifuge. Ann Dermatol Syphiligr 1916 ; 6 : 57-76.
 
P.101 掲載の参考文献
1) Darier J. De l'erytheme annulaire centrifuge. Ann Dermatol Syphiligr 1916 ; 6 : 57-76.
 
2) 宮川幸子. 環状紅斑の病態と分類 20世紀の総括. 西日皮膚 2001 ; 63 : 3-7.
 
3) Ackerman AB. Histologic Diagnosis of Inflammatory Skin Diseases. Philadelphia : Lea & Febiger ; 1978. pp174-5, 231-3, 283-4. (宮川幸子. 環状紅斑の病態と分類 20世紀の総括. 西日皮膚 2001 ; 63 : 3-7.)
 
4) Weyers W, Diaz-Cascajo C, Weyers I. Erythema annulare centrifugum. Results of a clinicopathologic study of 73 patients. Am J Dermatopathol 2003 ; 25 : 451-62.
PubMed
5) Ziemer M, Kisendle K, Zelger B. New concepts on erythema annulare centrifugum : a clinical reaction pattern that does not represent a specific clinicopathological entity. Br J Dermatol 2009 ; 160 : 119-26.
 
6) 竹中祐子, 林伸和. 環状紅斑. 日皮会誌 2008 ; 118 : 2407-14.
 
P.105 掲載の参考文献
1) Weber K. Remarks on the infectious disease caused by Borrelia burgdorferi. Zentralbl Bakteriol Mikcrobil Hyg 1986 ; 263 : 206-8.
PubMed
2) Buchner SA, Rufli T. Erythema chronicum migrans : evidence for cellular immune reaction in the skin lesion. Dermatologica 1987 ; 174 : 144-9.
PubMed
3) Mullegger RR, Means TK, Shin JJ, et al. Chemokine signature in the skin disorders of Lyme borreliosis in Europe : predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma. Infect Immun 2007 ; 75 : 4621-8.
PubMed
4) Steere AC. Lyme disease. N Engl J Med 1989 ; 321 : 586-96.
PubMed
5) Ciesielski CA, Markowitz LE, Horseley R, et al. The geographic distribution of Lyme disease in the United States. Ann NY Acad Sci 1988 ; 539 : 283-8.
 
6) 橋本喜夫, 飯塚一. 北海道のライム病の臨床と診断-自験113例の検討. MB Derma 2006 ; 114 : 46-53.
 
7) Yu XJ, Liang MF, Zhang SY, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med 2011 ; 364 : 1523-32.
 
8) 橋本喜夫, 木ノ内基史, 高橋英俊, ほか. 北海道のマダニ刺咬症-ライム病発症との関連. 日皮会誌 2002 ; 112 : 1467-73.
 
P.111 掲載の参考文献
1) 古川福実. 全身性エリテマトーデス. 玉置邦彦, ほか編. 最新皮膚科学大系 9. 膠原病 非感染性肉芽腫. 東京 : 中山書店 ; 2002. pp40-60.
 
2) Petri M, Orbai AM, Alarcon GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012 ; 64 : 2677-86.
PubMed
3) Furukawa F. Photosensitivity in cutaneous lupus erythematosus : lessons from mice and men. J Dermatol Sci 2003 ; 33 : 81-9.
 
4) 古川福実, 池田高治. 皮膚エリテマトーデス-最近の話題. 皮膚病診療 2009 ; 31 : 1134-40.
 
5) Ikeda T, Kanazawa N, Furukawa F. Hydroxychloroquine administration for Japanese lupus erythematosus in Wakayama : a pilot study. J Dermatol 2012 ; 39 : 531-5.
 
6) Yokogawa N, Tanikawa A, Amagai M, et al. Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI). Mod Rheumatol 2013 ; 23 : 318-22.
PubMed
P.118 掲載の参考文献
1) 加茂紘一郎, 長島正治. Sjogren症候群-紅斑を主訴とした1例を中心にして. 臨床皮膚科 1976 ; 30 : 761-71.
 
2) Rowell NR, Beck JS, Anderson JR. Lupus erythematosus and erythema multiforme-like lesions. A syndrome with characteristic immunological abnormalities. Arch Dermatol 1963 ; 88 : 176-80.
PubMed
3) Rekant SI, Becker LE. Auto-immune annular erythema. A variant of lupus erythematosus? Arch Dermatol 1973 ; 107 : 42-6.
 
4) Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus : a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 1979 ; 115 : 1409-15.
PubMed
5) Teramoto N, Katayama I, Arai H, et al. Annular erythema : a possible association with primary Sjogren's syndrome. J Am Acad Dermatol 1989 ; 20 : 596-601.
PubMed
6) Hoshino Y, Hashimoto T, Mimori T, et al. Recurrent annular erythema associated with anti-SS-B/La antibodies : analysis of the disease-specific epitope. Br J Dermatol 1992 ; 127 : 608-13.
PubMed
7) Kawakami T, Saito R. The relationship between facial annular erythema and anti-SS-A/Ro antibodies in three East Asian women. Br J Dermatol 1999 ; 140 : 136-40.
 
8) de Winter S, van Buchem MA, Vermeer MH. Annular erythema of Sjogren's syndrome. Lancet 2006 ; 367 : 1604.
PubMed
9) Katayama I, Kotobuki Y, Kiyohara E, et al. Annular erythema associated with Sjogren's syndrome : review of the literature on the management and clinical analysis of skin lesions. Mod Rheumatol 2010 ; 20 : 123-9.
PubMed
10) Provost TT, Watson R, Simmons-O'Brien E. Anti-Ro (SS-A) antibody positive Sjogren's/lupus erythematosus overlap syndrome. Lupus 1997 ; 6 : 105-11.
 
11) Kuhn A, Fehsel K, Lehmann P, et al. Aberrant timing in epidermal expression of inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus. J Invest Dermatol 1998 ; 111 : 149-53.
PubMed
12) Tsukazaki N, Watanabe M, Shimizu K, et al. Photoprovocation test and immunohistochemical analysis of inducible nitric oxide synthase expression in patients with Sjogren's syndrome associated with photosensitivity. Br J Dermatol 2002 ; 147 : 1102-8.
PubMed
13) Katayama I, Teramoto N, Arai H, et al. Annular erythema. A comparative study of Sjogren syndrome with subacute cutaneous lupus erythematosus. Int J Dermatol 1991 ; 30 : 635-9.
PubMed
14) Katayama I, Yamamoto T, Otoyama K, et al. Clinical and immunological analysis of annular erythema associated with Sjogren syndrome. Dermatology 1994 ; 189 suppl 1 : 14-7.
 
15) 片山一朗. 紅斑の分類と臨床検査・治療指針. MB Derma 2007 ; 122 : 1-5.
 
16) 片山一朗. 皮膚病変. 江口勝美, 編. シェーグレン症候群の手技・手法マニュアル. 長崎 : 日本シェーグレン研究会 ; 2000. pp147-54.
 
P.124 掲載の参考文献
1) McLean DI, Haynes HA. Cutaneous manifestation of internal disease : cutaneous paraneoplastic syndromes. In : Freedberg IM, et al, editors. Fitzpatrick's Dermatology in General Medicine. 6th ed. New York : McGraw-Hill ; 2003. pp1783-96.
 
2) Becker SW, Kahn D, Rothman S. Cutaneous manifestation of internal malignant tumors. Arch Derm Syphilol 1942 ; 45 : 1069-80.
 
3) Wilkinson DS. Necrolytic migratory erythema with carcinoma of the pancreas. Trans St Johns Hosp Dermatol Soc 1973 ; 59 : 244-50.
PubMed
4) Gammel JA. Erythema gyratum repens ; skin manifestations in patient with carcinoma of breast. AMA Arch Derm Syphilol 1952 ; 66 : 494-505.
PubMed
5) Kawakami T, Saito R. Erythema gyratum repens unassociated with underlying malignancy. J Dermatol 1995 ; 22 : 587-9.
PubMed
6) Honma M, Fujii M, Iimura S, et al. Erythema annulare centrifugum simulating erythema gyratum repens. J Dermatol 2011 ; 38 : 192-3.
 
7) Hashizume T, Kiryu H, Noda K, et al. Glucagonoma syndrome. J Am Acad Dermatol 1988 ; 19 : 337-83.
 
8) Magro C, Crownson AN, Dyrsen M, et al. Necrolytic migratory erythema (glucagonoma syndrome). In : Elder DE, et al, editors. Lever's Histopathology of the Skin. 10th ed. Philadelphia : Lippincott Williams & Wilkins ; 2009. p409.
 
9) Cox NH, Coulson IH. Systemic disease and the skin. In : Burns T, et al, editors. Rook's Textbook of Dermatology. 8th ed. Oxford : Wiley-Blackwell ; 2011. pp62.66-62.108.
 
10) 大竹映香, 伊藤恵子. 皮疹を契機に腎癌が発見されたerythema gyratum repens. 皮膚病診療 2012 ; 34 : 859-62.
 
11) Holt PJA, Davies MG. Erythema gyratum repens-an immunologically mediated dermatosis? Br J Dermatol 1977 ; 96 : 343-7.
 
12) Caux F, Lebbe C, Thomine E, et al. Erythema gyratum repens : a case studied with immunofluorescence, immunoelectron microscopy and immunohistochemistry. Br J Dermatol 1994 ; 131 : 102-7.
PubMed
13) 加瀬佳世子, 小俣光子, 漆畑修, ほか. Erythema figuratum neoplasticum (erythema gyratum repens) の1例. 臨床皮膚科 1992 ; 46 : 27-31.
 
14) 玉渕尚宏, 角田孝彦. 悪性腫瘍を伴わないerythema gyratum repensの1例. 皮膚科の臨床 2009 ; 51 : 717-8.
 
15) 鈴木典子, 村山功子, 吉池高志, ほか. 食道癌の摘出後に消退した好酸球増多を伴う環状紅斑の1例-特に内臓悪性腫瘍, 好酸球, 環状紅斑の相関について. 臨床皮膚科 2001 ; 55 : 946-8.
 
16) Shungaard A, Vercellotti G, Zanjani E, et al. Tumor-induced eosinophilia and endocardial fibrosis : evidence for ectopic eosinophilopoietin production and toxic O2 metabolite-mediated endothelial damage. Trans Assoc Am Physicians 1982 ; 95 : 8-11.
PubMed
17) 西山茂夫. 環状の紅斑. 皮膚病診療 1981 ; 1 : 1001-4.
 
18) 末木博彦, 榊原佳奈子. 内臓悪性腫瘍と紅斑. MB Derma 2007 ; 122 : 50-5.
 
P.129 掲載の参考文献
1) 幸田弘. 環状紅斑. 久木田淳, ほか編. 現代皮膚科学大系 12. 紅斑・滲出性紅斑 紫斑 水疱性疾患 膿疱性疾患. 東京 : 中山書店 ; 1980. pp25-35.
 
2) 川村哲也, 龍野一樹, 八木宏明. 9歳の女児に発症したerythema nodosum migrans. 臨床皮膚科 2008 ; 62 : 285-8.
 
3) 安田秀美, 小林仁, 大河原章, ほか. 本邦における小児汎発性膿疱性乾癬の疫学. 日皮会誌 1994 ; 104 : 759-66.
 
4) サンティス智恵, 浅賀美佐, 新井春枝, ほか. 環状の紅斑を混じた乳児水疱性類天疱瘡. 皮膚病診療 1999 ; 21 : 933-6.
 
5) 陣野原有利枝, 近藤靖児, 神保孝一, ほか. 小児の掌蹠に生じた環状肉芽腫の1例. 皮膚科の臨床 2001 ; 43 : 1704-5.
 
6) 土田哲也. Collagen disease in childhood. 日小皮会誌 2004 ; 23 : 173-6.
 
7) 土田哲也. 膠原病. MB Derma 2009 ; 157 : 21-5.
 
8) Furukawa F, Hiroi A. Collagen diseases in children. Clin Dermatol 2000 ; 18 : 725-33.
PubMed
9) 土田哲也, 盛岡奈緒子, 上田純嗣, ほか. エリテマトーデスの診断名と皮疹名. 皮膚科の臨床 1990 ; 32 : 1139-49.
 
10) Nikitakis NG, Rivera H, Lariccia C, et al. Primary Sjogren syndrome in childhood : report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003 ; 96 : 42-7.
PubMed
11) 小田真喜子, 雄山瑞栄, 清島真理子. 環状紅斑を伴った小児シェーグレン症候群. 日皮会誌 2004 ; 114 : 1781-6.
 
12) 藤田靖幸, 松村和子, 村田純子, ほか. 環状紅斑を契機に診断した小児Sjogren症候群の1例. 皮膚科の臨床 2006 ; 48 : 909-13.
 
13) 吉田まり子, 前山泰彦, 楠原正洋, ほか. 顔面に環状紅斑を生じた小児のsubclinical Sjogren syndrome. 皮膚病診療 2007 ; 29 : 555-8.
 
14) 太田馨, 岡本祐之, 二村省三. 顔面に環状紅斑の出没を繰り返した小児Sjogren症候群. 臨床皮膚科 2010 ; 64 : 734-8.
 
15) Civilibal M, Canpolat N, Yurt A, et al. A child with primary Sjogren syndrome and a review of the literature. Clin Pediatr 2007 ; 46 : 738-42.
 
16) 宮川幸子. 環状紅斑の病態と分類-20世紀の総括. 西日皮膚 2001 ; 63 : 3-7.
 
17) 太田真由美, 中川秀巳, 高畠典子, ほか. 抗U1-RNP抗体陽性の新生児エリテマトーデスの1例. 日小皮会誌 2008 ; 27 : 29-34.
 
18) 谷川瑛子. 全身性エリテマトーデス・SLE・シェーグレン症候群. MB Derma 2010 ; 164 : 109-15.
 
P.136 掲載の参考文献
1) 中條敦. 凍瘡ヲ合併セル續發性肥大性骨骨膜症. 皮泌誌 1939 ; 45 : 77-86.
 
2) 西村長應, 出来利夫, 加藤正一郎. 2家族に発生した凍瘡様皮膚病変を併発した続発性肥大性骨骨膜症. 皮性誌 1950 ; 60 : 136-41.
 
3) Kitano Y, Matsunaga E, Morimoto T, et al. A syndrome with nodular erythema, elongated and thickened fingers, and emaciation. Arch Dermatol 1985 ; 121 : 1053-6.
PubMed
4) 喜多野征夫. 凍瘡様皮疹を伴う骨骨膜症. 久木田淳, ほか編. 現代皮膚科学大系年刊版 '88-B. 東京 : 中山書店 ; 1988. pp163-5.
 
5) 田中正美, 田中一, 宮武 正. リポジストロフィーの新しい病型の提唱-関節拘縮, 結節性紅斑, 高γ-グロブリン血症を伴う常染色体劣性遺伝形式を示す脂肪筋萎縮症. 日本医事新報 1991 ; 3495 : 32-4.
 
6) Tanaka M, Miyatani N, Yamada S, et al. Hereditary lipo-muscular atrophy with joint contracture, skin eruptions and hyper-γ-globulinemia : a new syndrome. Intern Med 1993 ; 32 : 42-5.
 
7) 杉野禮俊, 小池通夫, 月野隆一, ほか. Partial lipodystrophyに酷似した外観を呈し, 凍瘡様皮疹, 長く節くれ立った指, 基底核石灰化を伴い, 炎症反応陽性を示す遺伝性疾患の4小児例. 疾患単位と考えたい. 日児誌 1986 ; 90 : 727.
 
8) 杉野禮俊, 新田康郎, 樋口隆造, ほか. Familial Japanese fever : partial lipodystrophyに酷似した外観を呈し, 凍瘡様皮疹, 長く節くれ立った指, 関節拘縮, 基底核石灰化などを伴う遺伝性発熱症候群. 日小医会報 2006 ; 32 : 106.
 
9) 古川福実. 厚生労働科学研究費補助金難治性疾患克服研究事業「中條-西村症候群の疾患概念の確立と病態解明へのアプローチ」平成21年度総括・分担研究報告書. 2010.
 
10) Arima K, Kinoshita A, Mishima H, et al. Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome. Proc Natl Acad Sci U S A 2011 ; 108 : 14914-9.
PubMed
11) Kitamura A, Maekawa Y, Uehara H, et al. A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. J Clin Invest 2011 ; 121 : 4150-60.
PubMed
12) Garg A, Hernandez MD, Sousa AB, et al. An autosomal recessive syndrome of joint contractures, muscular atrophy, microcytic anemia, and panniculitis-associated lipodystrophy. J Clin Endocrinol Metab 2010 ; 95 : E58-63.
PubMed
13) Torrelo A, Patel S, Colmenero I, et al. Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. J Am Acad Dermatol 2010 ; 62 : 489-95.
PubMed
14) Agarwal AK, Xing C, DeMartino GN, et al. PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. Am J Hum Genet 2010 ; 87 : 866-72.
 
15) Liu Y, Ramot Y, Torrelo A, et al. Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum 2012 ; 64 : 895-907.
 
16) Tanaka K. The proteasome : from basic mechanisms to emerging roles. Keio J Med 2013 ; 62 : 1-12.
PubMed
17) Fehling HJ, Swat W, Laplace C, et al. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 1994 ; 265 : 1234-7.
PubMed
P.142 掲載の参考文献
1) 金澤伸雄, 有馬和彦, 井田弘明, ほか. 中條-西村症候群. 日臨免誌 2011 ; 34 : 388-400.
 
2) Garg A, Hernandez MD, Sousa AB, et al. An autosomal recessive syndrome of joint contractures, muscular atrophy, microcytic anemia, and panniculitis-associated lipodystrophy. J Clin Endocrinol Metab 2010 ; 95 : E58-63.
PubMed
3) Liu Y, Ramot Y, Torrelo A, et al. Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum 2012 ; 64 : 895-907.
 
4) Gray PE, Bock V, Ziegler DS, et al. Neonatal Sweet syndrome : a potential marker of serious systemic illness. Pediatrics 2012 ; 129 : e1353.
PubMed
5) 喜多野征夫. 凍瘡様皮疹を伴う骨骨膜症. 久木田淳, ほか編. 現代皮膚科学大系年刊版 '88-B. 東京 : 中山書店 ; 1988. pp163-5.
 
6) Tanaka M, Miyatani N, Yamada S, et al. Hereditary lipo-muscular atrophy with joint contracture, skin eruptions and hyper-γ-globulinemia : a new syndrome. Intern Med 1993 ; 32 : 42-5.
 
7) 杉野禮俊, 小池通夫, 月野隆一, ほか. Partial lipodystrophyに酷似した外観を呈し, 凍瘡様皮疹, 長く節くれ立った指, 基底核石灰化を伴い, 炎症反応陽性を示す遺伝性疾患の4小児例. 疾患単位と考えたい. 日児誌 1986 ; 90 : 727.
 
8) Kunimoto K, Kimura A, Uede K, et al. A new infant case of Nakajo-Nishimura syndrome with a genetic mutation in the immunoproteasome subunit. An overlapping entity with JMP and CANDLE syndrome related to PMSB8 mutations. Dermatology 2013 ; 227 : 26-30.
 
9) Torrelo A, Patel S, Colmenero I, et al. Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. J Am Acad Dermatol 2010 ; 62 : 489-95.
PubMed
10) Fiorenza CG, Chou SH, Mantzoros CS. Lipodystrophy : pathophysiology and advances in treatment. Nat Rev Endocrinol 2011 ; 7 : 137-50.
PubMed
11) Oyanagi K, Sasaki K, Ohama E, et al. An autopsy case of a syndrome with muscular atrophy, decreased subcutaneous fat, skin eruption and hyper γ-globulinemia : peculiar vascular changes and muscle fiber degeneration. Acta Neuropathol 1987 ; 73 : 313-9.
 
12) Crow YJ, Rehwinkel J. Aicardi-Goutieres syndrome and related phenotypes : linking nucleic acid metabolism with autoimmunity. Hum Mol Genet 2009 ; 18 : R130-6.
PubMed
13) Kasagi S, Kawano S, Nakazawa T, et al. A case of periodic-fever-syndrome-like disorder with lipodystrophy, myositis, and autoimmune abnormalities. Mod Rheumatol 2008 ; 18 : 203-7.
PubMed
P.149 掲載の参考文献
1) 樋口謙太郎. 一種の點状紅斑に就て. 皮と泌 1943 ; 11 : 171-2.
 
2) 谷村忠保, 吉野一正, 坂本邦樹, ほか. 一種の點状紅斑について. 臨床皮膚泌尿器科 1954 ; 8 : 135-7.
 
3) 田中勝. 点状紅斑 (樋口). 玉置邦彦, ほか編. 最新皮膚科学大系 4. 紅斑・滲出性紅斑 紫斑 脈管系の疾患. 東京 : 中山書店 ; 2003. pp61-2.
 
4) Cherry JD, Bobinski JE, Horvath FL, et al. Acute hemangioma-like lesions associated with echo viral infections. Pediatrics 1969 ; 44 : 498-502.
PubMed
5) Prose NS, Tope W, Miller SE, et al. Eruptive pseudoangiomatosis : a unique childhood exanthema? J Am Acad Dermatol 1993 ; 29 : 857-9.
 
6) 白井明, 日野治子. 点状紅斑 (樋口). Visual Dermatology 2005 ; 4 : 590-2.
 
7) Ban M, Ichiki Y, Kitajima Y. An outbreak of eruptive pseudoangiomatosis-like lesions due to mosquito bites : erythema punctatum Higuchi. Dermatology 2004 ; 208 : 356-9.
PubMed
8) Oka K, Ohtaki N, Kasai S, et al. Two cases of eruptive pseudoangiomatosis induced by mosquito bites. J Dermatol 2012 ; 39 : 301-5.
PubMed
9) 大原一枝, 藤田尚信, 南路子. 樋口氏点状紅斑と蚊刺. 臨床皮膚泌尿器科 1965 ; 19 : 699-705.
 
10) Oka K, Ohtaki N. Clinical observation of mosquito bite reactions in man : a survey of the relationship between age and bite reaction. J Dermatol 1989 ; 16 : 212-9.
 
11) Restano L, Cavalli R, Colonna C, et al. Eruptive pseudoangiomatosis caused by an insect bite. J Am Acad Dermatol 2005 ; 52 : 174-5.
PubMed
12) Navarro V, Molina I, Montesinos E, et al. Eruptive pseudoangiomatosis in an adult. Int J Dermatol 2000 ; 39 : 236-40.
 
13) Larralde M, Ballona R, Correa N, et al. Eruptive pseudoangiomatosis. Pediatr Dermatol 2002 ; 19 : 76-7.
 
14) Pitarch G, Torrijos A, Garcia-Escriva D, et al. Eruptive pseudoangiomatosis associated to cytomegalovirus infection. Eur J Dermatol 2007 ; 17 : 455-6.
PubMed
15) Neri I, Patrizi A, Guerrini V, et al. A new case of eruptive pseudoangiomatosis : ultrastructural study. J Eur Acad Dermatol Venereol 2004 ; 18 : 387-9.
PubMed
16) 占部治邦, 柿添富久子, 丸田宏幸, ほか. 樋口点状紅斑様皮疹を呈した薬疹. 西日皮膚 1970 ; 32 : 337-41.
 
17) Kim JE, Kim BJ, Park HJ, et al. Clinicopathologic review of eruptive pseudoangiomatosis in Korean adults : report of 32 cases. Int J Dermatol 2013 ; 52 : 41-5.
PubMed
P.153 掲載の参考文献
1) Perera GA. A note palmar erythema (so-called liver palms). JAMA 1942 ; 119 : 1417-8.
 
2) Serrao R, Zirwas M, English JC. Palmar erythema. Am J Clin Dermatol 2007 ; 8 : 347-56.
PubMed
3) Bean W. Acquired palmar erythema and cutaneous vascular spider. Am Heart J 1943 ; 25 : 463-77.
 
4) Sodhi VK, Sausker WF. Dermatosis of pregnancy. Am Fam Physician 1998 ; 37 : 131-8.
 
P.158 掲載の参考文献
1) Pernet G. Symmetrical lividities of the soles of the feet. Br J Dermatol 1925 ; 37 : 23-5.
 
2) Hitch JM, Hansen RF. Symmetric erythema of soles : symmetrical lividities of the soles of the feet (Pernet). Arch Dermatol Syphilol 1938 ; 38 : 881-92.
 
3) Park RG. Hyperhidrosis of the feet. Arch Dermatol Syphilol 1943 ; 48 : 538.
 
4) Rietschel RL, Carr JF, Lewis CW. Symmetrical lividity of the palms and soles. Int J Dermatol 1978 ; 17 : 739-44.
PubMed
5) Kearse HL, Nagy R. Symmetric lividities-therapy with aluminum chloride solution. J Am Acad Dermatol 1986 ; 15 : 539-40.
PubMed
6) Shelley WB, Shelley ED. Symmetrical lividity of the soles. Cutis 1999 ; 64 : 175-6.
PubMed
7) Neri I, Guareschi E, Patrizi A. Symmetrical lividity in an infant. Pediatr Dermatol 2004 ; 21 : 521-2.
 
8) 広瀬至, 比留間政太郎. 局所多汗症の足縁に見られた浮腫性, 紅斑性局面の2例. 日皮会誌 1979 ; 89 : 209.
 
9) Nelson LM. Symmetric lividity of the soles. Arch Dermatol Syphilol 1943 ; 47 : 822-5.
 
10) Nelson LM. Symmetric lividity of the soles as seen in private practice. Calif Med 1956 ; 85 : 248-9.
PubMed
11) 森川玲子, 熊切正信, 三浦祐晶, ほか. Symmetrical lividities of the soles of the feet. 皮膚科の臨床 1982 ; 24 : 943-8.
 
12) 信原聡美, 松吉徳久, 戸田憲一, ほか. Symmetrical Lividities of the Soles of the Feetの1例. 皮膚科紀要 1998 ; 93 : 531-6.
 
13) 花川博義, 野村佳弘. 健康サンダルにより生じたSymmetrical Lividities of the Soles of the Feetの1例. 皮膚科の臨床 1997 ; 39 : 378-9.
 
14) 安田秀世, 松原邦彦, 宮内東光, ほか. 軽石による刺激で発症したSymmetrical Lividities of the Soles of the Feetの1例. 皮膚科の臨床 1999 ; 41 : 1566-7.
 
15) 筬井泰江, 富永晃広, 兼子理恵, ほか. Symmetrical lividities of the palms and solesの1例. 皮膚科の臨床 2008 ; 50 : 1156-7.
 
16) 大島英恵, 松崎康司, 中野創, ほか. Symmetrical lividities of the soles of the feetの1例. 日皮会誌 2011 ; 121 : 2498.
 
17) 長坂晶子, 大森正幸, 島田眞路. Symmetrical lividities of the palms and solesにより診断に至ったBasedow病の1例. 臨床皮膚科 2003 ; 57 : 603-5.
 
18) Rengioletti F, Tomasini C, Crovato F, et al. Aquagenic (pseudo) keratoderma : a clinical series with new pathological insights. Br J Dermatol 2012 ; 167 : 575-82.
 
19) Luo DQ. Aquagenic acrokeratoderma : a case with family history and unusual involvements of the palms and soles, and the dorsum of fingers and toes. J Dermatol 2011 ; 38 : 612-5.
PubMed
20) 友寄貴子, 熊切正信, 小泉洋子, ほか. Symmetrical lividities of the palms and solesの1例. 皮膚科の臨床 1991 ; 33 : 1740-1.
 
21) 吉井章, 堀川澄, 小野友道. Symmetrical lividities of the palms and soles. 皮膚病診療 1994 ; 16 : 1017-20.
 
22) 筒井真人, 伊藤文彦, 飯塚一, ほか. イオントフォレーシスが有効であったsymmetrical lividities of the soles of the feetの1例. 臨床皮膚科 1994 ; 48 : 115-7.
 

II 痒疹群

P.166 掲載の参考文献
1) 佐藤貴浩, 横関博雄, 片山一朗, ほか. 日本皮膚科学会ガイドライン 慢性痒疹診療ガイドライン. 日皮会誌 2012 ; 122 : 1-16.
 
P.167 掲載の参考文献
1) Mukai K, Matsuoka K, Taya C, et al. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 2005 ; 23 : 191-202.
PubMed
2) Yoshimoto T, Yasuda K, Tanaka H, et al. Basophils contribute to T (H) 2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4 (+) T cells. Nature Immunology 2009 ; 10 : 706-12.
 
3) Karasuyama H, Mukai K, Obata K, et al. Nonredundant roles of basophils in immunity. Annu Rev Immunol 2011 ; 29 : 45-69.
PubMed
4) Mitchell EB, Crow J, Chapman MD, et al. Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet 1982 ; 1 : 127-30.
PubMed
5) Ugajin T, Kojima T, Mukai K, et al. Basophils preferentially express mouse mast cell protease 11 among the mast cell tryptase family in contrast to mast cells. J Leukoc Biol 2009 ; 86 : 1417-25.
PubMed
6) Agis H, Krauth MT, Bohm A, et al. Identification of basogranulin (BB1) as a novel immunohistochemical marker of basophils in normal bone marrow and patients with myeloproliferative disorders. Am J Clin Pathol 2006 ; 125 : 273-81.
PubMed
7) Ito Y, Satoh T, Takayama K, et al. Basophil recruitment and activation in inflammatory skin diseases. Allergy 2011 ; 66 : 1107-13.
PubMed
8) Hashimoto T, Satoh T, Yokozeki H. Repeated induction of IgE-mediated chronic skin inflammation induces prurigo-like skin lesions. The 36th Annual Meeting of the Japanese Society for Investigative Dermatology. Kyoto. 2011. p9-19.
 
9) Park K, Mori T, Nakamura M, et al. Increased expression of mRNAs for IL-4, IL-17, IL-22 and IL-31 in skin lesions of subacute and chronic forms of prurigo. Eur J Dermatol 2011 ; 21 : 135-6.
PubMed
10) Kabu K, Yamasaki S, Kamimura D, et al. Zinc is required for FcεRI-mediated mast cell activation. J Immunol 2006 ; 177 : 1296-305.
 
11) Nishida K, Hasegawa A, Nakae S, et al. Zinc transporter Znt5/Slc30a5 is required for the mast cell-mediated delayed-type allergic reaction but not the immediatetype reaction. J Exp Med 2009 ; 206 : 1351-64.
 
12) Ugajin T, Nishida K, Yamasaki S, et al. Metallothionein regulates IL-4 production by basophils. The 41st Annual Meeting of the Japanese Society for Immunology. Tokyo. 2012.
 
P.172 掲載の参考文献
1) 芝間さやか, 端本宇志, 並木剛, ほか. 【痒疹反応】<臨床例> 痒疹反応を伴った全身型クロムアレルギー. 皮膚病診療 2011 ; 33 : 1251-4.
 
2) 西澤綾, 佐藤貴浩, 横関博雄. 【痒疹反応】<臨床例> 歯性根尖病巣が原因と考えられた亜急性痒疹. 皮膚病診療 2011 ; 33 : 1219-22.
 
P.174 掲載の参考文献
1) Wallengren J. Prurigo : diagnosis and management. Am J Clin Dermatol 2004 ; 5 : 85-95.
PubMed
2) 小林由紀子, 中川秀己. クロムイオン曝露による結節性痒疹. MB Derma 2002 ; 68 : 50-3.
 
3) 足立厚子. 金属接触アレルギーと全身型金属アレルギーの診断について. J Environ Dermatol Cutan Allergol 2011 ; 5 : 1-10.
Medical*Online
4) 矢口厚, 米元康蔵. 亜急性痒疹を伴った慢性リンパ性白血病. 皮膚病診療 1997 ; 19 : 847-50.
 
5) 渡邊亜紀, 古賀哲也, 利谷昭治. 悪性腫瘍摘出後に消失した亜急性痒疹の2例. 皮膚科の臨床 1999 ; 41 : 203-7.
 
6) 小金井宏美, 東直行, 荻田あづさ, ほか. 皮膚症状を契機に前立腺癌が発見された3例. 皮膚科の臨床 2010 ; 52 : 1467-71.
 
7) Gelfand JM, Rudikoff D. Evaluation and treatment of itching in HIV-infected patients. Mt Sinai J Med 2001 ; 68 : 298-308.
PubMed
8) Baglieri F, Scuderi G. Disseminated Kaposi's sarcoma and HCV infection : only a casual relationship? A case report. G Ital Dermatol Venereol 2009 ; 144 : 317-20.
 
9) Saporito L, Florena AM, Colomba C, et al. Prurigo nodularis due to Mycobacterium tuberculosis. J Med Microbiol 2009 ; 58 : 1649-51.
PubMed
10) Wedi B, Kapp A. Helicobacter pylori infection in skin diseases : a critical appraisal. Am J Clin Dermatol 2002 ; 3 : 273-82.
PubMed
11) 森理, 上田嘉乃, 長治順子, ほか. 齲歯, 歯周囲炎の病巣感染による多形慢性痒疹の1例. 臨床皮膚科 1999 ; 53 : 312-3.
 
12) Satoh T, Takayama K, Sawada Y, et al. Chronic nodular prurigo associated with nummular eczema : possible involvement of odontogenic infection. Acta Derm Venereol 2003 ; 83 : 376-7.
PubMed
13) 西澤綾, 佐藤貴浩, 横関博雄. 【痒疹反応】<臨床例> 歯性根尖病巣が原因と考えられた亜急性痒疹. 皮膚病診療 2011 ; 33 : 1219-22.
 
P.179 掲載の参考文献
1) 佐藤貴浩, 横関博雄, 片山一朗, ほか. 日本皮膚科学会ガイドライン 慢性痒疹診療ガイドライン. 日皮会誌 2012 ; 122 : 1-16.
 
2) 入沢該吉. 慢性痒疹について. 皮膚科の臨床 1964 ; 6 : 622-35.
 
3) 三浦修. 痒疹群. 皮膚科の臨床 1968 ; 10 : 1045-53.
 
4) 帷子康雄. 痒疹. 久木田淳, ほか編. 現代皮膚科学大系 13. 湿疹 痒疹 蕁麻疹. 東京 : 中山書店 ; 1980. pp161-90.
 
5) 長島正治. 痒疹丘疹の特徴. 皮膚科の臨床 1995 ; 37 : 1211.
 
6) 籏野倫. 痒疹をめぐって. 皮膚病診療 1979 ; 1 : 594-600.
 
7) 西山茂夫. 痒疹の今昔-伊藤実先生にきく. 皮膚病診療 1979 ; 1 : 642-51.
 
8) 西山茂夫, 森俊二, 山本達雄, ほか. 痒疹の諸問題. 皮膚病診療 1997 ; 19 : 869-79.
 
9) Rowland-Payne CME, Wilkinson JD, Mckee PH, et al. Nodular prurigo-a clinicopathological study of 46 patients. Br J Dermatol 1985 ; 113 : 431-9.
 
10) Burton JL, Holden CA. Eczema, Lichenification and prurigo. In : Champion RH, et al, editors. Textbook of Dermatology. 6th ed. Oxford : Blackwell Science ; 1998. pp671-4.
 
11) 山本達雄. 多形慢性痒疹. 皮膚病診療 1985 ; 7 : 1119-22.
 
12) Doyle JA, Connolly SM, Hunziker N, et al. Prurigo nodularis, a reappraisal of the clinical and histologic features. J Cutan Pathol 1979 ; 6 : 392-403.
PubMed
13) Ito Y, Satoh T, Takayama K, et al. Basophil recruitment and activation in inflammatory skin diseases. Allergy 2011 ; 66 : 1107-13.
PubMed
P.184 掲載の参考文献
1) Akashi R, Ishiguro N, Shimizu S, et al. Clinical study of the relationship between Helicobacter pylori and chronic urticaria and prurigo chronica multiformis : effectiveness of eradication therapy for Helicobacter pylori. J Dermatol 2011 ; 38 : 761-6.
PubMed
2) Sakurane M, Shiotani A, Furukawa F. Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients. J Dermatol 2002 ; 29 : 23-7.
PubMed
3) Shiotani A, Okada K, Yanaoka K, et al. Beneficial effect of Helicobacter pylori eradication in dermatologic diseases. Helicobacter 2001 ; 6 : 60-5.
PubMed
4) Fujii K, Kanno Y, Konishi K, et al. Short-term etretinate therapy for prurigo chronica multiformis. J Dermatol 2002 ; 29 : 146-51.
PubMed
5) Lee MR, Shumack S. Prurigo nodularis : a review. Australas J Dermatol 2005 ; 46 : 211-8. quiz 219-20.
 
6) Weigelt N, Metze D, Stander S. Prurigo nodularis : systematic analysis of 58 histological criteria in 136 patients. J Cutan Pathol 2010 ; 37 : 578-86.
PubMed
7) Johansson O, Liang Y, Heilborn JD, et al. Langerhans cells in prurigo nodularis investigated by HLA-DR and S-100 immunofluorescence double staining. J Dermatol Sci 1998 ; 17 : 24-32.
PubMed
8) Andersen TP, Fogh K. Thalidomide in 42 patients with prurigo nodularis Hyde. Dermatology 2011 ; 223 : 107-12.
PubMed
9) Tominaga M, Ogawa H, Takamori K. Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis. Br J Dermatol 2008 ; 158 : 842-4.
PubMed
10) Liang Y, Jacobi HH, Reimert CM, et al. CGRP-immunoreactive nerves in prurigo nodularis-an exploration of neurogenic inflammation. J Cutan Pathol 2000 ; 27 : 359-66.
PubMed
11) Sonkoly E, Muller A, Lauerma AI, et al. IL-31 : a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006 ; 117 : 411-7.
PubMed
12) Otsuka A, Tanioka M, Nakagawa Y, et al. Effects of cyclosporine on pruritus and serum IL-31 levels in patients with atopic dermatitis. Eur J Dermatol 2011 ; 21 : 816-7.
PubMed
13) Arita K, South AP, Hans-Filho G, et al. Oncostatin M receptor-β mutations underlie familial primary localized cutaneous amyloidosis. Am J Hum Genet 2008 ; 82 : 73-80.
 
P.189 掲載の参考文献
1) Shelley WB, Arthur RP. The neurohistology and neurophysiology of the itch sensation in man. AMA Arch Derm 1957 ; 76 : 296-323.
PubMed
2) Schmelz M, Schmidt R, Bickel A, et al. Specific C-receptor for itch in human skin. J Neurosci 1997 ; 17 : 8003-8.
PubMed
3) Sun YG, Chen ZF. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 2007 ; 448 : 700-3.
PubMed
4) Tominaga M, Ozawa S, Tengara S, et al. Intraepidermal nerve fibers increase in dry skin of acetone-treated mice. J Dermatol Sci 2007 ; 48 : 103-11.
PubMed
5) Tominaga M, Kamo A, Tengara S, et al. In vitro model for penetration of sensory nerve fibers on a Matrigel basement membrane : implication for possible application to intractable pruritus. Br J Dermatol 2009 ; 161 : 1028-37.
PubMed
6) Bernstein JE, Swift RM, Soltani K, et al. Antipruritic effect of an opiate antagonist, naloxone hydrochloride. J Invest Dermatol 1982 ; 78 : 82-3.
PubMed
7) Pan ZZ. μ-opposing actions of the κ-opioid receptor. Trends Pharmacol Sci 1998 ; 19 : 94-8.
 
8) Tominaga M, Takamori K. Recent advances in pathophysiological mechanisms of itch. Expert Rev Dermatol 2010 ; 5 : 197-212.
 
9) Stander S, Siepmann D, Herrgott I, et al. Targeting the neurokinin receptor 1 with aprepitant : a novel antipruritic strategy. PLos One 2010 ; 5 : e10968.
PubMed
10) Raap U, Wichmann K, Bruder M, et al. Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol 2008 ; 122 : 421-3.
PubMed
11) Steinhoff M, Neisius U, Ikoma A, et al. Proteinase-activated receptor-2 mediates itch : a novel pathway for pruritus in human skin. J Neurosci 2003 ; 23 : 6176-80.
PubMed
12) Thurmond RL, Gelfand EW, Dunford PJ. The role of histamine H1 and H4 receptors in allergic inflammation : the search for new antihistamines. Nat Rev Drug Discov 2008 ; 7 : 41-53.
PubMed
13) Tominaga M, Ogawa H, Takamori K. Histological characterization of cutaneous nerve fibers containing gastrin-releasing peptide in NC/Nga mice : an atopic dermatitis model. J Invest Dermatol 2009 ; 129 : 2901-5.
 
14) Bigliardi PL, Bigliard-Qi M, Buechner S, et al. Expression of μ-opiate receptor in human epidermis and keratinocytes. J Invest Dermatol 1998 ; 111 : 297-301.
 
15) Tominaga M, Ogawa H, Takamori K. Possible role of epidermal opioid system in pruritus of atopic dermatitis. J Invest Dermatol 2007 ; 127 : 2228-35.
 
16) Phan NQ, Bernhard JD, Luger TA, et al. Antipruritic treatment with systemic μ-opioid receptor antagonists : a review. J Am Acad Dermatol 2010 ; 63 : 680-8.
 
17) Dawn AG, Yosipovitch G. Butorphanol for treatment of intractable pruritus. J Am Acad Dermatol 2006 ; 54 : 527-31.
PubMed
18) Stander S, Luger T, Metze D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 2001 ; 44 : 471-8.
PubMed
19) Stander S, Schurmeyer-Horst F, Luger TA, et al. Treatment of pruritic diseases with topical calcineurin inhibitors. Ther Clin Risk Manag 2006 ; 2 : 213-8.
PubMed
20) Siepmann D, Luger TA, Stander S. Antipruritic effect of cyclosporine microemulsion in prurigo nodularis : results of a case series. J Dtsch Dermatol Ges 2008 ; 6 : 941-6.
 
21) Schuhknecht B, Marziniak M, Wissel A, et al. Reduced intraepidermal nerve fibre density in lesional and nonlesional prurigo noduralis skin as a potential sign of subclinical cutaneous neuropathy. Br J Dermatol 2011 ; 165 : 85-91.
PubMed
22) Lee MR, Shumack S. Prurigo nodularis : a review. Australas J Dermatol 2005 ; 46 : 211-8.
PubMed
23) Wallengren J, Sundler F. Phototherapy reduces the number of epidermal and CGRP-positive dermal nerve fibers. Acta Derm Venereol 2004 ; 84 : 111-5.
PubMed
24) Tominaga M, Tengara S, Kamo A, et al. Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervations in atopic dermatitis. J Dermatol Sci 2009 ; 55 : 40-6.
PubMed
25) Kamo A, Tominaga M, Tengara S, et al. Inhibitory effects of UV-based therapy on dry skin-inducible nerve growth in acetone-treated mice. J Dermatol Sci 2011 ; 62 : 91-7.
 
P.198 掲載の参考文献
1) 佐藤貴浩, 横関博雄, 片山一朗, ほか. 日本皮膚科学会ガイドライン 慢性痒疹診療ガイドライン. 日皮会誌 2012 ; 122 : 1-16.
 
2) 入沢該吉. 慢性痒疹について. 皮膚科の臨床 1964 ; 6 : 622-35.
 
3) Rowland-Payne CME, Wilkinson JD, Mckee PH, et al. Nodular prurigo-a clinicopathological study of 46 patients. Br J Dermatol 1985 ; 113 : 431-9.
 
4) 山本達雄. 高齢者の皮膚病 : 多形慢性痒疹. 皮膚病診療 1985 ; 7 : 1119-22.
 
5) Lutz W. Mitteilungen-Communications Neurodermitis. Dermatologica 1949 ; 98 : 1-22.
 
6) 太藤重夫. 丘疹-紅皮症. 皮膚科紀要 1987 ; 82 : 89-91.
 
7) Shiohara T, Doi T, Hayakawa J. Defective sweating responses in atopic dermatitis. In : Shiohara T, editor. Pathogenesis and Management of Atopic Dermatitis (Current Problems in Dermatology 41). Basel : Karger ; 2011. pp68-79.
 
P.203 掲載の参考文献
1) Doyle JA, Connolly SM, Hunziker N, et al. Prurigo nodularis : a reappraisal of the clinical and histologic features. J Cutan Pathol 1979 ; 6 : 392-403.
PubMed
2) Rea JN, Newhouse ML, Halil T. Skin disease in Lambeth. A community study of prevalence and use of medical care. Br J Prev Soc Med 1976 ; 30 : 107-14.
 
3) 古江増隆, 山崎雙次, 神保孝一, ほか. 本邦における皮膚科受診患者の多施設横断四季別全国調査. 日皮会誌 2009 ; 119 : 1795-809.
 
4) 室田浩之, 北場俊, 谷守, ほか. かゆみを伴う皮膚疾患患者での労働生産性の評価とヒスタミンH1拮抗薬による改善効果の検討. Progress in Medicine 2009 ; 29 : 1842-8.
Medical*Online
5) Murota H, Kitaba S, Tani M, et al. Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases. Allergol Int 2010 ; 59 : 345-54.
PubMed
6) Reilly Associates. http://www.reillyassociates.net/
 
7) Thompson AK, Finn AF, Schoenwetter WF. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. J Am Acad Dermatol 2000 ; 43 : 24-30.
PubMed
8) Pearce DJ, Singh S, Balkrishnan R, et al. The negative impact of psoriasis on the workplace. J Dermatolog Treat 2006 ; 17 : 24-8.
PubMed
9) Reilly MC, Lavin PT, Kahler KH, et al. Validation of the Dermatology Life Quality Index and the Work Productivity and Activity Impairment-Chronic Hand Dermatitis questionnaire in chronic hand dermatitis. J Am Acad Dermatol 2003 ; 48 : 128-30.
PubMed
10) Murota H, Kitaba S, Tani M, et al. Effects of nonsedative antihistamines on productivity of patients with pruritic skin diseases. Allergy 2010 ; 65 : 929-30.
PubMed
P.208 掲載の参考文献
1) 佐藤貴浩, 横関博雄, 片山一朗, ほか. 日本皮膚科学会ガイドライン 慢性痒疹診療ガイドライン. 日皮会誌 2012 ; 122 : 1-16.
 
P.213 掲載の参考文献
1) 佐藤貴浩, 横関博雄, 片山一朗, ほか. 日本皮膚科学会ガイドライン 慢性痒疹診療ガイドライン. 日皮会誌 2012 ; 122 : 1-16.
 
P.216 掲載の参考文献
1) 古江増隆, 佐伯秀久, 古川福実, ほか. 日本皮膚科学会アトピー性皮膚炎診療ガイドライン作成委員会. アトピー性皮膚炎診療ガイドライン. 日皮会誌 2009 ; 119 : 1515-34.
 
2) 西山茂夫, 岡本昭二, 石橋康正, ほか. KW-4679 (塩酸オロパタジン) 錠の掻痒性皮膚疾患に対する臨床試験. 臨床医薬 1996 ; 12 : 1615-40.
Medical*Online
3) 石橋康正, 原田昭太郎, 新村眞人, ほか. KG-2413 (フマル酸エメダスチン) の湿疹・皮膚炎群, 痒疹群および皮膚掻痒症に対する一般臨床試験. 臨床医薬 1994 ; 10 : 1919-35.
 
4) 佐藤貴浩, 横関博雄, 片山一朗, ほか. 慢性痒疹診療ガイドライン. 日皮会誌 2012 ; 122 : 1-16.
 
5) 五十嵐敦之, ネオーラル(R) によるアトピー性皮膚炎治療研究会. 成人の重症アトピー性皮膚炎患者を対象としたシクロスポリンMEPCとプラセボとの比較試験 : 多施設共同, ランダム化, 二重盲検並行群間比較試験. 臨床皮膚科 2009 ; 63 : 73-82.
 
6) Siepmann D, Luger TA, Stander S. Antipruritic effect of cyclosporine microemulsion in prurigo nodularis : results of a case series. J Dtsch Dermatol Ges 2008 ; 6 : 941-6.
 
7) Berth-Jones J, Smith SG, Graham-Brown RA. Nodular prurigo responds to cyclosporin. Br J Dermatol 1995 ; 132 : 795-9.
PubMed
8) Andersen TP, Fogh K. Thalidomide in 42 patients with prurigo nodularis Hyde. Dermatology 2011 ; 223 : 107-12.
PubMed
9) Taefehnorooz H, Truchetet F, Barbaud A, et al. Efficacy of thalidomide in the treatment of prurigo nodularis. Acta Derm Venereol 2011 ; 91 : 344-5.
PubMed
10) 手塚匡哉. Bednar'sアフタを合併した多形慢性痒疹の女性例に対する補中益気湯と黄連解毒湯の使用経験. 新薬と臨床 2005 ; 54 : 749-53.
 
11) 水島宣昭. 多形慢性痒疹に奏効した黄連解毒湯. 老化と疾患 1995 ; 8 : 1649-51.
 
12) 手塚匡哉. 痒疹に対する温清飲の使用経験. 漢方研究 2003 ; (383) : 14-6.
 
13) 田原英一, 新谷卓弘, 中尾紀久世, ほか. 大柴胡湯加減が奏効した結節性痒疹の1例. 漢方の臨床 2007 ; 54 : 1107-10.
 
14) 田中哲二. 月経時に増悪する難治性全身性痒疹に柴苓湯が著効した1例. Progress in Medicine 2000 ; 20 : 2275-7.
Medical*Online
P.220 掲載の参考文献
1) 佐藤貴浩, 横関博雄, 片山一朗, ほか. 日本皮膚科学会ガイドライン 慢性痒疹診療ガイドライン. 日皮会誌 2012 ; 122 : 1-16.
 
1) Wallengren J, Sundler F. Phototherapy reduces the number of epidermal and CGRP-positive dermal nerve fibres. Acta Derm Venereol 2004 ; 84 : 111-5.
PubMed
2) 戸倉新樹. 紫外線による免疫抑制と樹状細胞. 臨床免疫・アレルギー科 2011 ; 56 : 434-41.
 
3) 森田明理. 【皮膚科最新光線療法マニュアル】光線療法の将来に向けて-新しいナローバンドUVBとUVA1. MB Derma 2006 ; 116 : 1-9.
 
4) 龍野一樹, 戸倉新樹. 【慢性痒疹と皮膚掻痒症の病態と治療】慢性痒疹・皮膚掻痒症の光線療法. アレルギー・免疫 2012 ; 19 : 944-9.
 
5) Tomura M, Honda T, Tanizaki H, et al. Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J Clin Invest 2010 ; 120 : 883-93.
 
6) Yoshiki R, Kabashima K, Sakabe J, et al. The mandatory role of IL-10-producing and OX40 ligand-expressing mature Langerhans cells in local UVB-induced immunosuppression. J Immunol 2010 ; 184 : 5670-7.
PubMed
7) Hammes S, Hermann J, Roos S, et al. UVB 308-nm excimer light and bath PUVA : combination therapy is very effective in the treatment of prurigo nodularis. J Eur Acad Dermatol Venereol 2011 ; 25 : 799-803.
PubMed
8) Tamagawa-Mineoka R, Katoh N, Ueda E, et al. Narrow-band ultraviolet B phototherapy in patients with recalcitrant nodular prurigo. J Dermatol 2007 ; 34 : 691-5.
PubMed
9) Gambichler T, Hyun J, Sommer A, et al. A randomised controlled trial on photo (chemo) therapy of subacute prurigo. Clin Exp Dermatol 2006 ; 31 : 348-53.
 
10) Tominaga M, Tengara S, Kamo A, et al. Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis. J Dermatol Sci 2009 ; 55 : 40-6.
PubMed
P.225 掲載の参考文献
1) 西山茂夫. 痒疹. 皮膚病診療 1979 ; 1 : 601-4.
 
2) Huang XJ, Li HY, Chen DX, et al. Clinical analysis of skin lesions in 796 Chinese HIV-positive patients. Acta Derm Venereol 2011 ; 91 : 552-6.
PubMed
3) 佐藤貴浩, 横関博雄, 片山一朗, ほか. 日本皮膚科学会ガイドライン 慢性痒疹診療ガイドライン. 日皮会誌 2012 ; 122 : 1-16.
 
4) Katayama I, Miyazaki Y, Nishioka K. Topical vitamin D3 (tacalcitol) for steroidresistant prurigo. Br J Dermatol 1996 ; 135 : 237-40.
PubMed
5) Wong SS, Goh CL. Double-blind, right/left comparison of calcipotriol ointment and betamethasone ointment in the treatment of prurigo nodularis. Arch Dermatol 2000 ; 136 : 807-8.
PubMed
6) 片山一朗, 末吉富美子, 田中洋一. 頑固で慢性の痒み. Visual Dermatology 2003 ; 2 : 928-9.
 
7) 曽我部陽子, 安部正敏, 石川治. 結節性痒疹. Visual Dermatology 2005 ; 4 : 276-7.
 
8) Fukuoka M, Ogino Y, Sato H, et al. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Br J Dermatol 1998 ; 138 : 63-70.
PubMed
9) Fukuya Y, Higaki M, Higaki Y, et al. Effect of vitamin D3 on the increased expression of Bcl-xL in psoriasis. Arch Dermatol Res 2002 ; 293 : 620-5.
PubMed
10) Barrat FJ, Cua DJ, Boonstra A, et al. In vitro generation of interleukin 10-producing regulatory CD4 (+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1) - and Th2-inducing cytokines. J Exp Med 2002 ; 195 : 603-16.
 
11) Fukuoka M, Sakurai K, Ohta T, et al. Tacalcitol, an active vitamin D3, induces nerve growth factor production in human epidermal keratinocytes. Skin Pharmacol Appl Skin Physiol 2001 ; 14 : 226-33.
PubMed
P.231 掲載の参考文献
1) 長島正治, 大城晶子, 清水夏江. 掻痒性紅色丘疹を前駆し網目状色素斑を残す一疾患について. 日皮会誌 1971 ; 81 : 78-91.
 
2) 松下佳代, 戸倉新樹, 八木宏明, ほか. 血中ケトン体高値を示した色素性痒疹の3例. 臨床皮膚科 1997 ; 51 : 333-6.
 
3) Boer A, Misago N, Wolter M, et al. Prurigo pigmentosa : a distinctive inflammatory disease of the skin. Am J Dermatopathol 2003 ; 25 : 117-29.
PubMed
4) Kim JK, Chung WK, Chang SE, et al. Prurigo pigmentosa : clinicopathological study and analysis of 50 cases in Korea. J Dermatol 2012 ; 39 : 891-7.
 
5) Oh YJ, Lee MH. Prurigo pigmentosa : a clinicopathological study of 16 cases. J Eur Acad Dermatol Venereol 2012 ; 26 : 1149-53.
 
6) 長島正治, 大草康弘. 色素性痒疹をふりかえる. 臨床皮膚科 1991 ; 45 (5 増) : 7-11.
 
7) Nagashima M. Prurigo pigmentosa-clinical observations of our 14 cases. J Dermatol 1978 ; 5 : 61-7.
 
8) Kubota Y, Koga T, Nakayama J. Bullous prurigo pigmentosa and diabetes. Eur J Dermatol 1998 ; 8 : 439-41.
PubMed
9) 一宮誠, 濱本嘉昭, 武藤正彦. インスリン治療開始とともに痒疹の消褪をみたsoft drink ketosis. 皮膚病診療 2000 ; 22 : 553-6.
 
10) 三橋善比古, 鈴木紀子, 青木武彦. ペットボトル症候群と色素性痒疹. 臨床皮膚科 2002 ; 56 (5 増) : 170-2.
 
11) 篠塚直子, 藤本智子, 稲澤美奈子, ほか. 型糖尿病を合併し膿疱形成のみられた色素性痒疹. 皮膚病診療 2011 ; 33 : 1247-50.
 
12) Teraki Y, Teraki E, Kawashima M, et al. Ketosis is involved in the origin of prurigo pigmentosa. J Am Acad Dermatol 1996 ; 34 : 509-11.
PubMed
13) 雨森正記, 西垣逸郎, 荻野賢二, ほか. 色素性痒疹を合併したインスリン依存型糖尿病 (IDDM) の一例. 糖尿病 1989 ; 32 : 547-51.
 
14) 齋藤昌孝, 石河晃, 寺木祐一, ほか. 慶應義塾大学医学部皮膚科学教室で経験した色素性痒疹60例の臨床的検討. 臨床皮膚科 2004 ; 58 : 483-7.
 
15) 山田研太郎, 高根直子, 野中共平, ほか. ケトーシスを伴って急性発症する肥満NIDDM症例-清涼飲料水ケトーシス. 糖尿病 1993 ; 36 : 469-74.
 
16) 野中共平. ソフトドリンクケトーシス-日本社会の歪みを具現. 臨牀と研究 2010 ; 87 : 17-8.
 
17) 盛岡奈緒子, 竹原和彦, 大塚藤男, ほか. 女性用下着の圧迫部位に一致して分布した色素性痒疹の2例. 皮膚科の臨床 1990 ; 32 : 113-6.
 
18) 藤田裕介, 勝岡憲生, 荒井亮, ほか. 色素性痒疹-当科23例の集計と病理組織学的および免疫組織化学的検討. 西日皮膚 1994 ; 56 : 749-57.
 
19) 富田靖, 舛真一, 斉藤信也. 色素性痒疹-dyskeratotic cellの存在と組織学的色素失調の形成について. 臨床皮膚科 1979 ; 33 : 933-8.
 
20) 折原緑, 寺木祐一, 長島正治, ほか. 色素性痒疹-毛包周囲に細胞浸潤を認めた3症例の検討. 臨床皮膚科 1996 ; 50 : 9-12.
 
21) 早川和人, 塩原哲夫. 色素性痒疹のミノサイクリン療法. 臨床皮膚科 1997 ; 51 (5 増) : 116-9.
 
22) Parneix-Spake A, Bastuji-Garin S, Lobut J-B, et al. Minocycline as possible cause of severe and protracted hypersensitivity drug reaction. Arch Dermatol 1995 ; 131 : 490-1.
PubMed
23) 矢島千穂, 熊切正信. Minocycline が著効を示した色素性痒疹の3例. 皮膚科の臨床 1992 ; 34 : 955-60.
 
P.236 掲載の参考文献
1) Kroumpouzos G, Cohen LM. Dermatoses of pregnancy. J Am Acad Dermatol 2001 ; 45 : 1-19.
PubMed
2) Ambros-Rudolph CM. Dermatoses of pregnancy. J Dtsch Dermatol Ges 2006 ; 4 : 748-59.
PubMed
3) Beard MP, Millington GW. Recent developments in the specific dermatoses of pregnancy. Clin Exp Dermatol 2012 ; 37 : 1-4.
PubMed
4) Ambros-Rudolph CM, Mullegger RR, Vaughan-Jones SA, et al. The specific dermatoses of pregnancy revisited and reclassified : results of a retrospective twocenter study on 505 pregnant patients. J Am Acad Dermatol 2006 ; 54 : 395-404.
 
5) Lawley TJ, Hertz KC, Wade TR, et al. Pruritic urticarial papules and plaques of pregnancy. JAMA 1979 ; 241 : 1696-9.
PubMed
6) Rudolph CM, Al-Fares S, Vaughan-Jones SA, et al. Polymorphic eruption of pregnancy : clinicopathology and potential trigger factors in 181 patients. Br J Dermatol 2006 ; 154 : 54-60.
PubMed
7) Ahmadi S, Powell FC. Pruritic urticarial papules and plaques of pregnancy : current status. Australas J Dermatol 2005 ; 46 : 53-8.
PubMed
8) Matz H, Orion E, Wolf R. Pruritic urticarial papules and plaques of pregnancy : polymorphic eruption of pregnancy (PUPPP). Clin Dermatol 2006 ; 24 : 105-8.
PubMed
9) Sato Y, Teraki Y, Izaki S, et al. Ritodrine-induced erythematous papular eruption in 14 pregnant women. Int J Dermatol 2010 ; 49 : 1450-3.
PubMed
P.241 掲載の参考文献
1) 紫芝敬子. 妊娠に伴うひふの変化 (綜説). MB Derma 2006 ; 36 : 1-6.
 
2) Holmes RC, Black MM. The specific dermatoses of pregnancy. J Am Acad Dermatol 1983 ; 8 : 405-12.
PubMed
3) Shornick JK. Dermatoses of pregnancy. Semin Cutan Med Surg 1998 ; 17 : 172-81.
PubMed
4) Shornick JK. Pregnancy dermatoses. In : Bolognia JL, et al, editors. Dermatology. 2nd ed. St Louis : Mosby/Elsevier ; 2008. pp396-402.
 
5) Karen JK, Pomeranz MK. Skin changes and disease in pregnancy. In : Wolff K, et al, editors. Fitzpatrick's Dermatology in General Medicine. 7th ed. New York : McGraw-Hill ; 2009. pp955-62.
 
6) Ambros-Rudolph CM, Mullegger RR, Vaughan-Jones SA, et al. The specific dermatoses of pregnancy revisited and reclassified : result of a retrospective twocenter study on 505 pregnant patients. J Am Acad Dermatol 2006 ; 54 : 395-404.
 
7) Karen JK, Pomeranz MK. Skin changes and disease in pregnancy. In : Goldsmith LA, et al, editors. Fitzpatrick's Dermatology in General Medicine. 8th ed. New York : McGraw-Hill ; 2012. pp1204-12.
 
8) 慶田朋子, 川上理子. 妊婦614人に認めた皮膚病変の統計学的調査. 日皮会誌 2006 ; 116 : 41-50.
 
9) Ingber A. Atopic eruption of pregnancy. J Eur Acad Dermatol Venereol 2010 ; 24 : 984.
PubMed
10) Ambros-Rudolph CM, Shornick JK. Pregnancy dermatoses. In : Bolognia JL, et al, editors. Dermatology. 3rd ed. Philadelphia : Elsevier Saunders ; 2012. pp439-48.
 
11) Ambros-Rudolph CM. Dermatoses of pregnancy-clue to diagnosis, fetal risk and therapy. Ann Dermatol 2011 ; 23 : 265-75.
 
P.247 掲載の参考文献
1) 片桐一元. 内臓悪性腫瘍を検索すべき皮膚疾患. 日本医事新報 2011 ; (4542) : 73-7.
Medical*Online
1) Kis LL, Gerasimcik N, Salamon D, et al. STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2 : implications for the type II EBV latent gene expression in Hodgkin lymphoma. Blood 2011 ; 117 : 165-74.
PubMed
2) Curth HO. Skin manifestations of internal malignant tumors. Md State Med J 1972 ; 21 : 52-6.
PubMed
3) 植村文子, 山元修, 戸倉新樹. 【悪性腫瘍と皮膚 臨床例】多形慢性痒疹-内臓悪性腫瘍に随伴した難治例. 皮膚病診療 2005 ; 27 : 655-8.
 
4) 桑原慎治, 江藤宏光, 齊藤典充, ほか. 【痒疹反応】<臨床例> 胃癌切除後に症状が改善した多形慢性痒疹. 皮膚病診療 2011 ; 33 : 1227-30.
 
5) Fina L, Grimalt R, Berti E, et al. Nodular prurigo associated with Hodgkin's disease. Dermatologica 1991 ; 182 : 243-6.
PubMed
6) Seshadri P, Rajan SJ, George IA, et al. A sinister itch : prurigo nodularis in Hodgkin lymphoma. J Assoc Physicians India 2009 ; 57 : 715-6.
PubMed
7) 原田洋至, 元木良和, 丹治修, ほか. 内臓悪性腫瘍を合併した結節性痒疹の2例. 皮膚科の臨床 1994 ; 36 : 811-4.
 
8) 谷口隆志, 菅谷誠, 佐藤伸一. 【おさえておきたい, リンパ腫の鑑別と治療】結節性痒疹との鑑別を要したT細胞リンパ腫. Visual Dermatology 2012 ; 11 : 934-5.
 
9) 神園政行, 瀬戸山充, 田代正昭. 【malignant lymphomaの皮膚病変】痒疹と悪性リンパ腫-痒疹様先行病変を認めたATLの1例. 皮膚病診療 1992 ; 14 : 243-6.
 
10) Riesco Martinez MC, Munoz Martin AJ, Zamberk Majlis P, et al. Acquired ichthyosis as a paraneoplastic syndrome in Hodgkin's disease. Clin Transl Oncol 2009 ; 11 : 552-3.
PubMed
11) Skinnider BF, Elia AJ, Gascoyne RD, et al. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2002 ; 99 : 618-26.
PubMed
12) 片桐一元. 皮膚バリア機能とアトピー性皮膚炎. J Environ Dermatol Cutan Allergol 2010 ; 4 : 4-14.
Medical*Online
13) 植田郁子, 白崎文朗, 齋藤敦, ほか. 確定診断7年前より経過を追うことができた菌状息肉症の1例. 日皮会誌 2009 ; 119 : 893-8.
 
14) 片桐一元. 痒疹の治療. 皮膚病診療 2011 ; 33 : 1275-80.
 
P.254 掲載の参考文献
1) Chey WY, Kim KL, Yoo TY, et al. Allergic contact dermatitis from hair dye and development of lichen simplex chronicus. Contact Dermatitis 2004 ; 51 : 5-8.
PubMed
2) 足立厚子, 堀川達弥. 全身型金属アレルギー : 食餌制限の有効性について. 臨床皮膚科 1992 ; 46 : 883-9.
 
3) 足立厚子. 金属接触アレルギーと全身型金属アレルギーの診断について. J Environ Dermatol Cutan Allergol 2011 ; 5 : 1-10.
Medical*Online
4) 鈴木加余子, 松永佳世子, 矢上晶子, ほか. ジャパニーズスタンダードアレルゲン (1994) の2005年度～2007年度陽性率とジャパニーズスタンダードアレルゲン (2008) の2009年度陽性率. J Environ Dermatol Cutan Allergol 2012 ; 6 : 67-84.
Medical*Online
5) Fisher AA. Systemic contact-type dermatitis. In : Fisher AA, editor. Contact Dermatitis. 3rd ed. Philadelphia : Lea & Febiger ; 1986. pp119-30.
 
6) Veien NK, Hattel T, Justesen O, et al. Oral challenge with metal salts. (I). vesicular patch-test-negative hand eczema. Contact Dermatitis 1983 ; 9 : 402-6.
PubMed
7) Adachi A, Horikawa T. The significance, problem and method of oral provocation test in metal allergy. Environ Dermatol 1999 ; 6 : 74-82.
 
8) 鷲尾文郎, 足立厚子, 近藤真史, ほか. ビタミンB12製剤による薬疹 : 臨床的特徴およびコバルトアレルギーの関与について. 皮膚病診療 1994 ; 16 : 597-600.
 

書評

最近チェックした商品履歴

Loading...